<?xml version="1.0" encoding="UTF-8"?>
<definitions publication-date="2023-08-01" publication-type="official">
<definition-item date-revised="2021-08-01"><classification-symbol scheme="cpc">C07K</classification-symbol><definition-title>PEPTIDES  (peptides in foodstuffs <class-ref scheme="cpc">A23</class-ref>; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs <class-ref scheme="cpc">A23J</class-ref>; preparations for medicinal purposes <class-ref scheme="cpc">A61K</class-ref>; peptides containing beta-lactam rings <class-ref scheme="cpc">C07D</class-ref>; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, <class-ref scheme="cpc">C07D</class-ref>; ergot alkaloids of the cyclic peptide type <class-ref scheme="cpc">C07D519/02</class-ref>; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids <class-ref scheme="cpc">C08G69/00</class-ref>; macromolecular products derived from proteins <class-ref scheme="cpc">C08H1/00</class-ref>; preparation of glue or gelatine <class-ref scheme="cpc">C09H</class-ref>; single cell proteins, enzymes <class-ref scheme="cpc">C12N</class-ref>; genetic engineering processes for obtaining peptides <class-ref scheme="cpc">C12N15/00</class-ref>; compositions for measuring or testing processes involving enzymes <class-ref scheme="cpc">C12Q</class-ref>; investigation or analysis of biological material <class-ref scheme="cpc">G01N33/00</class-ref>)</definition-title><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">An amino acid per se is classified in&#160;<class-ref scheme="cpc">C07D</class-ref>&#160;while peptides (starting from dipeptides) are classified in&#160;<class-ref scheme="cpc">C07K</class-ref>.</paragraph-text><paragraph-text type="body">Subclass&#160;<class-ref scheme="cpc">C07K</class-ref>&#160;is a function oriented entry for the compounds themselves and does not cover the application or use of the compounds under the subclass definition. For classifying such information other entries exist, for example: preservation of bodies of humans or animals or plants or parts thereof; Biocides, e.g. as disinfectants, as pesticides, as herbicides; pest repellants or attractants; plant growth regulators are classified in&#160;<class-ref scheme="cpc">A01N</class-ref>.</paragraph-text><paragraph-text type="body">Preparations for medical, dental, or toilet purposes are classified in&#160;<class-ref scheme="cpc">A61K</class-ref>.</paragraph-text><paragraph-text type="body">Amino acids or derivatives thereof are classified in&#160;<class-ref scheme="cpc">C07C</class-ref>&#160;or&#160;<class-ref scheme="cpc">C07D</class-ref>.</paragraph-text><paragraph-text type="subheading">Multiple Classification</paragraph-text><paragraph-text type="body">Biocidal, pest repellant, pest attractant, or plant growth regulatory activity of chemical compounds or preparations is classified in&#160;<class-ref scheme="cpc">A01P</class-ref>.</paragraph-text><paragraph-text type="body">Therapeutic activity of chemical compounds or medicinal preparations is further classified in subclass <class-ref scheme="cpc">A61P</class-ref>.</paragraph-text><paragraph-text type="body">Uses of cosmetics or similar toilet preparations are further classified in&#160;<class-ref scheme="cpc">A61Q</class-ref>.</paragraph-text></section-body></relationship><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Peptides containing beta-lactam rings</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07D</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Cyclic dipeptides not having in their molecule any other peptide link than those which form their ring; e.g. piperazine-2,5-diones</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07D</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Ergot alkaloids of the cyclic peptide type</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07D519/02</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Genetic engineering processes for obtaining peptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides and proteins obtained by fermentation or enzyme-using processes are classified in</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12P21/00</class-ref> - <class-ref scheme="cpc">C12P21/06</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Electrolytic production of organic compounds</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C25B3/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Peptides in foodstuffs</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23J1/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides in animal feed</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23K20/147</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific, but for a random sequence of the amino acid units, homopolyamides and block copolyamids derived from amino acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C08G69/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Macromolecular products derived from proteins</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C08H1/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preparation of glue or gelatine</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C09H</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Compositions for measuring or testing processes involving enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Analytical devices</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Investigation or analysis of biological materials</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/00</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">In this subclass, in the absence of an indication to the contrary, a compound is classified in the last appropriate place.</paragraph-text><paragraph-text type="body">Fragments of peptides or peptides modified by removal or addition of amino acids, by substitution of amino acids by others, or by combination of these modifications are classified as the parent peptides (however only if they have the same activity). Peptide fragments having up to four amino acids are classified in group <class-ref scheme="cpc">C07K5/00</class-ref>.</paragraph-text><paragraph-text type="body">Peptides prepared by chemical processes or having an amino acid sequence derived from naturally occurring peptides are classified with the naturally occurring peptide.</paragraph-text><paragraph-text type="body">Peptides prepared by recombinant DNA technology are not classified according to the host, but according to the original peptide expressed, e.g. HIV peptide expressed in E. coli is classified with HIV peptides.</paragraph-text><paragraph-text type="body">When classifying in this subclass, classification is also made in group <class-ref scheme="cpc">B01D15/08</class-ref> insofar as subject matter of general interest relating to chromatography is concerned.</paragraph-text><paragraph-text type="body">Specific peptides mentioned in the claims and/or examples are classified.</paragraph-text><paragraph-text type="body">The technical field of <class-ref scheme="cpc">C07K1/00</class-ref>&#160;-&#160;<class-ref scheme="cpc">C07K5/126</class-ref> is subdivided into three major blocks:</paragraph-text><table>
<table-row><table-column preferred-width="9.72cm"><paragraph-text type="body">General methods for preparation of peptides/proteins</paragraph-text></table-column><table-column preferred-width="5.32cm"><paragraph-text type="body"><class-ref scheme="cpc">C07K1/00</class-ref> - <class-ref scheme="cpc">C07K1/13</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column preferred-width="9.72cm"><paragraph-text type="body">General methods for extraction, separation and purification of proteins and peptides</paragraph-text></table-column><table-column preferred-width="5.32cm"><paragraph-text type="body"><class-ref scheme="cpc">C07K1/14</class-ref> - <class-ref scheme="cpc">C07K1/36</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column preferred-width="9.72cm"><paragraph-text type="body">Peptide compounds per se containing up to four amino acids </paragraph-text></table-column><table-column preferred-width="5.32cm"><paragraph-text type="body"><class-ref scheme="cpc">C07K5/00</class-ref> - <class-ref scheme="cpc">C07K5/126</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column preferred-width="9.72cm"><paragraph-text type="body">Should not be used anymore for classification</paragraph-text></table-column><table-column preferred-width="5.32cm"><paragraph-text type="body"><class-ref scheme="cpc">C07K2/00</class-ref>, <class-ref scheme="cpc">C07K4/00</class-ref></paragraph-text></table-column></table-row></table></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Amino acid</paragraph-text></table-column><table-column><paragraph-text type="body">compounds in which at least one amino acid group and at least one carboxylic group are bound to the same carbon skeleton and the nitrogen atom of the amino group may be part of a ring</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Normal peptide link</paragraph-text></table-column><table-column><paragraph-text type="body">a link between an alpha-amino group of an amino acid and the carboxylic group in position 1 of another alpha-amino acid</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Abnormal peptide link</paragraph-text></table-column><table-column><paragraph-text type="body">a link where at least one of the linked amino acids is not an alpha- amino acid or a link formed by at least one carboxyl or amino group being a part of the side chain of an alpha-amino acid. Peptide compounds containing at least two amino acid units, which are bound through at least one normal peptide link, including oligopeptides, polypeptides and proteins.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Linear peptides</paragraph-text></table-column><table-column><paragraph-text type="body">may comprise rings formed through S-S bridges, or through an hydroxy or a mercapto group of an hydroxy- or a mercapto-amino acid and the carboxyl group of another amino acid (e.g. peptide lactones) but do not comprise rings which are formed only through peptide links.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Cyclic peptides</paragraph-text></table-column><table-column><paragraph-text type="body">comprising at least one ring formed only through peptide links; the cyclisation may occur only through normal peptide links or through abnormal peptide links, e.g. through the 4-amino group of 2,4-diamino-butanoic acid. Thus, cyclic compounds in which at least one link in the ring is a non-peptide link are considered as&apos; linear peptides&apos;.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Depsipeptides</paragraph-text></table-column><table-column><paragraph-text type="body">compounds containing a sequence of at least two alpha-amino acids and at least one alpha-hydroxy carboxylic acid, which are bound through at least one normal peptide link and ester link, derived from the hydroxy carboxylic acids</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Linear depsipeptides</paragraph-text></table-column><table-column><paragraph-text type="body">may comprise rings formed through S-S bridges, or through an hydroxy or a mercapto group of an hydroxy- or mercapto-amino and and the carboxyl group of another amino- or hydroxy-acid but do not comprise rings formed only through peptide or ester links derived from hydroxy carboxylic acids, e.g. Gly-Ala-Gly-OCH2CO2H and Gly-OCH2CO-Ala-Gly are considered as &quot;linear depsipeptides, but HOCH2CO-Gly-Ala-Gly does not contain an ester link, and is thus a derivative of Gly-Ala-Gly which is covered by <class-ref scheme="cpc">C07K5/08</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Cyclic depsipeptides</paragraph-text></table-column><table-column><paragraph-text type="body">are peptides containing at least one ring formed only through peptide or ester link - derived from hydroxy carboxylic acids -, e.g. Gly-Ala-Gly-OCH2CO</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Hybrid peptides</paragraph-text></table-column><table-column><paragraph-text type="body">are peptides produced through fusion or covalent binding of two or more heterologous peptides.</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K1/00</classification-symbol><definition-title>General methods for the preparation of peptides {, i.e. processes for the organic chemical preparation of peptides or proteins of any length}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">General processes for the organic chemical preparation of peptides (exception see <class-ref scheme="cpc">C07K1/113</class-ref>).</paragraph-text><paragraph-text type="body">Peptides e.g. oligopeptides, polypeptides, proteins Immunoglobulins.</paragraph-text><paragraph-text type="body">Carrier-bound or immobilised peptides and preparation thereof.</paragraph-text><paragraph-text type="body">Hybridpeptides.</paragraph-text><paragraph-text type="body">&quot;Peptides&quot; in this main group includes oligopeptides, polypeptides, proteins and chemically modified forms thereof, i.e. the definition of peptide is independent of the length in amino acids.</paragraph-text><paragraph-text type="body">Peptides comprise at least two alpha-amino acids joined by a single peptide bond.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K1/003</classification-symbol><definition-title>{by transforming the C-terminal amino acid to amides}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Reactions concerning transformation of the C-terminal amino acid to amides.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K1/006</classification-symbol><definition-title>{of peptides containing derivatised side chain amino acids}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Preparation of peptides containing derivatised side chain amino acids such as e.g. pseudo proline, non natural amino acids, and chemically phosphorylated amino acids.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K1/02</classification-symbol><definition-title>in solution {(<class-ref scheme="cpc">C07K1/003</class-ref>, <class-ref scheme="cpc">C07K1/006</class-ref> take precedence)}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">General methods for solution phase peptide synthesis.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Main group concerns methods for solution phase peptide synthesis applicable to peptides in general. Methods directed to solution phase peptide synthesis of a single peptide or protein needs to be classified in the pertinent group for that specific peptide or protein.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C07K1/003</class-ref>, <class-ref scheme="cpc">C07K1/006</class-ref> take precedence.</paragraph-text><paragraph-text type="body">The class <class-ref scheme="cpc">C07K1/023</class-ref> should be given if the focus of solution phase peptide synthesis is on inhibition of racemate formation.</paragraph-text><paragraph-text type="body">Solution-phase peptide synthesis may comprise enzymes as catalysts.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Peptides</paragraph-text></table-column><table-column><paragraph-text type="body">oligopeptides, polypeptides, proteins and chemically modified forms thereof.</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K1/04</classification-symbol><definition-title>on carriers {(<class-ref scheme="cpc">C07K1/003</class-ref>, <class-ref scheme="cpc">C07K1/006</class-ref> take precedence)}</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body"><class-ref scheme="cpc">C07K1/003</class-ref>, <class-ref scheme="cpc">C07K1/006</class-ref> take precedence.</paragraph-text><paragraph-text type="body">Specific aspects of synthesis on carriers, such as deprotection, new solvents, should be classified in the respective subclasses.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K1/045</classification-symbol><definition-title>{using devices to improve synthesis, e.g. reactors, special vessels}</definition-title><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Apparatus per se </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">B01J19/0046</class-ref>, <class-ref scheme="cpc">B01J19/0093</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K1/047</classification-symbol><definition-title>{Simultaneous synthesis of different peptide species; Peptide libraries}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Organic chemical methods for simultaneous multiple peptide synthesis and organic chemical synthesis of peptide libraries.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Carrier-bound immobilised peptides are classified in, if the invention relies in the carrier and/or the anchoring linkages</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K17/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptide libraries produced by recombinant DNA technology </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1034</class-ref> - <class-ref scheme="cpc">C12N15/1093</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Libraries per se, arrays, containing peptides or polypeptides, or derivatives thereof </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B40/10</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Combinatorial chemical libraries </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B50/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K1/06</classification-symbol><definition-title>using protecting groups or activating agents {(<class-ref scheme="cpc">C07K1/003</class-ref>, <class-ref scheme="cpc">C07K1/006</class-ref> take precedence)}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">General methods for the preparation of peptides using protecting groups or activating agents.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Multiple classification if a plurality of protecting groups is claimed.</paragraph-text><paragraph-text type="body">Please avoid, where possible, classification in the head group <class-ref scheme="not-mapped">C07K/06</class-ref>,</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C07K1/003</class-ref>, <class-ref scheme="cpc">C07K1/006</class-ref> take precedence.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K1/08</classification-symbol><definition-title>using activating agents {(<class-ref scheme="cpc">C07K1/003</class-ref>, <class-ref scheme="cpc">C07K1/006</class-ref> take precedence)}</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body"><class-ref scheme="cpc">C07K1/003</class-ref>, <class-ref scheme="cpc">C07K1/006</class-ref> take precedence.</paragraph-text><paragraph-text type="body">For coupling of peptides the carboxyl group is activated. Thus activating agent are generally agents which activate the carboxyl group by forming an activated ester, such as DCC, DIC, BOP, PyBOP, HBTU, TBTU.</paragraph-text><paragraph-text type="body">Activating agents are to be distiguished from coupling agents which do not form an activated ester but are oxidized during the peptide bond formation.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K1/10</classification-symbol><definition-title>using coupling agents {(<class-ref scheme="cpc">C07K1/006</class-ref> takes precedence)}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">General methods for the preparation of peptides using coupling agents.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body"><class-ref scheme="cpc">C07K1/006</class-ref> takes precedence.</paragraph-text><paragraph-text type="body">For coupling of peptides the carboxyl group is activated. Thus activating agent are generally agents which activate the carboxyl group by forming an activated ester, such as DCC, DIC, BOP, PyBOP, HBTU, TBTU.</paragraph-text><paragraph-text type="body">Activating agents are to be distinguished from coupling agents which do not form an activated ester but are oxidized during the peptide bond formation.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K1/1077</classification-symbol><definition-title>{by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">General methods for the preparation of peptides by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Carrier-bound immobilised peptides </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K17/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptide libraries produced by recombinant DNA technology </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1034</class-ref> - <class-ref scheme="cpc">C12N15/1093</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Libraries per se, arrays, containing peptides or polypeptides, or derivatives thereof </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B40/10</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Combinatorial chemical libraries </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B50/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Peptide arrays or libraries are NOT classified in <class-ref scheme="cpc">C07K1/1077</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K1/113</classification-symbol><definition-title>without change of the primary structure</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">General methods for the preparation of peptides without change in the primary structure, e.g. by reversible modification of the secondary, tertiary or quaternary structure.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">In this subclass as an exception to the general rule that methods have to be applicable to peptides in general, exceptionally also methods relating to a single peptide or protein are classified.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K1/12</classification-symbol><definition-title>by hydrolysis {, i.e. solvolysis in general}</definition-title><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Peptides obtained by fermentation </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12P21/00</class-ref> - <class-ref scheme="cpc">C12P21/06</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Documents directed to peptide or protein sequencing have also been classified in the past in <class-ref scheme="cpc">G01N33/68</class-ref>.</paragraph-text><paragraph-text type="body">General methods for the preparation of peptides by hydrolysis covers peptide or protein sequencing techniques (sequential hydrolysis of peptides or protein).</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2017-08-01"><classification-symbol scheme="cpc">C07K1/13</classification-symbol><definition-title>Labelling of peptides</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">General chemical methods for the preparation of peptides by labelling e.g. with dyes, radioactive or fluorescents labels.</paragraph-text><paragraph-text type="body">Subgroup concerns methods which are applicable to peptides of any length in general! Methods directed to the preparation of a specific peptide or protein needs to be classified in the pertinent group for that specific peptide or protein.</paragraph-text></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">Isotope labelled peptides per se are classified in <class-ref scheme="cpc">C07B59/008</class-ref>.</paragraph-text></section-body></relationship><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Peptide conjugates where the innovation is on the conjugated part </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K47/50</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides forming the non active part of a conjugate for use as a therapeutic agent</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K47/62</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides forming the non active part of a conjugate for use as an in vivo imaging agent by fluorescense</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K49/0056</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides possibly part of a conjugate, for use as an in vivo imaging agent by X-ray imaging</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K49/04</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"> Peptides possibly part of a conjugate for use as an in vivo imaging agent by magnetic resonance imaging</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K49/14</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"> Peptides possibly part of a conjugate for use as an in vivo imaging agent by ultrasound imaging </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K49/22</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preparations containing radioactive peptides for use in therapy and in vivo imaging are classified in Preparations containing radioactive peptides for use in therapy and in vivo imaging</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K51/08</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K1/14</classification-symbol><definition-title>Extraction; Separation; Purification</definition-title><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><paragraph-text type="body">Methods directed to purification of antibodies from serum, plasma, or other body fluids are classified in <class-ref scheme="cpc">C07K16/065</class-ref>. However, if the focus is on technical aspect of purification as such, the method should also be classified in <class-ref scheme="cpc">C07K1/14</class-ref> - <class-ref scheme="cpc">C07K1/36</class-ref>. Purification of antibodies from a solution, cell culture, and the like, is classified in <class-ref scheme="cpc">C07K1/14</class-ref> - <class-ref scheme="cpc">C07K1/36</class-ref>.</paragraph-text></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Antibodies isolated from milk are also classified in</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K2317/12</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Please avoid where you can classifying in the head group.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K1/16</classification-symbol><definition-title>by chromatography</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Only chromatographic methods applicable for peptides or proteins as such are classified here.</paragraph-text></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">Chromatographic materials as such are classified in <class-ref scheme="cpc">B01J20/281</class-ref> - <class-ref scheme="cpc">B01J20/292</class-ref>, <class-ref scheme="cpc">B01J39/26</class-ref> (cation exchangers), <class-ref scheme="cpc">B01J41/20</class-ref> (anion exchangers).</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">B01D15/08</class-ref> relates to processes and apparatus for chromatography in general.</paragraph-text></section-body></relationship></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K1/306</classification-symbol><definition-title>{by crystallization}</definition-title><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Methods with emphasis on growing large single crystals of protein from solutions </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C30B7/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">For the crystal</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C30B29/58</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K1/36</classification-symbol><definition-title>by a combination of two or more processes of different types</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">A combination of two or more processes of different types means that at least two steps are innovative.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K2/00</classification-symbol><definition-title>Peptides of undefined number of amino acids; Derivatives thereof</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Please avoid classifying in this group. Consider classification only in exceptional cases where the protein is not identifiable by the sequence or otherwise.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K4/00</classification-symbol><definition-title>Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Please avoid classifying in this group. Consider classification only in exceptional cases where the protein is not identifiable by the sequence or otherwise.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2017-08-01"><classification-symbol scheme="cpc">C07K5/00</classification-symbol><definition-title>Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Peptides containing up to four amino acids in a fully defined sequence and derivatives thereof. Peptides containing up to four amino acids in a fully defined sequence and containing saccharide radicals are not covered by this group (see references relevant to classification below). </paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Peptides containing up to four amino acids in a fully defined sequence and containing saccharide radicals</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K9/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Cosmetic preparations containing peptides </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K8/64</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Medical uses of novel short peptides </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K38/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Dipeptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K38/05</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Tripeptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K38/06</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Tetrapeptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K38/07</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Depsipeptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K38/15</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Depsipeptides with up to 4 amino acids are also classified in</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K11/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"> Chemically synthesized hybrid peptides with up to 4 amino acids are also classified in</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K19/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"> Fusion polypeptides </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K2319/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptide conjugates where the innovation is on the conjugated part are classified in</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K47/50</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"> Peptides up to 4 amino acids in length forming the non active part of a conjugate, for use as a therapeutic agent, are also classified in</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K47/62</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides up to 4 amino acids in length forming the active part of a conjugate to an antibody, for use as a therapeutic agent, are also classified in</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K47/6801</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides up to 4 amino acids in length forming the non active part of a conjugate, for use as an in vivo imaging agent by fluorescense, are also classified in </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K49/0056</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides up to 4 amino acids in length, possibly part of a conjugate, for use as an in vivo imaging agent by X-ray imaging, are also classified in</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K49/04</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"> Peptides up to 4 amino acids in length, possibly part of a conjugate, for use as an in vivo imaging agent by magnetic resonance imaging, are also classified in </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K49/14</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides up to 4 amino acids in length, possibly part of a conjugate, for use as an in vivo imaging agent by ultrasound imaging, are also classified in </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K49/22</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preparations containing radioactive peptides for use in therapy and in vivo imaging are also classified in</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K51/08</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides with up to 4 amino acids labelled with isotopes are also classified in </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07B59/008</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides with up to four amino acids prepared by fermentation (not recombinantly expressed) are also classified in</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12P21/00</class-ref>- <class-ref scheme="cpc">C12P21/06</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Although <class-ref scheme="cpc">C07K5/00</class-ref>- <class-ref scheme="cpc">C07K5/126</class-ref> concern short peptides per se, there is one exception: methods for purification and preparation of aspartame are classified with aspartame in <class-ref scheme="cpc">C07K5/0613</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K5/02</classification-symbol><definition-title>containing at least one abnormal peptide link</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Peptides per se, and derivatives thereof, having up to four amino acids in a fully defined sequence and containing at least one abnormal peptide link are classified in this subgroup only.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Mainly protease inhibitors, such as statins, have been classified here.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K5/0217</classification-symbol><definition-title>{containing the structure -C(=O)-C-N-C(=O)-N-C-C(=O)-}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Peptides, and derivatives thereof, having up to four amino acids in a fully defined sequence and containing the structure [-C(=O)-C-N-C(=O)-N-C-C(=O)-]</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Peptides with symmetrical structure.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K5/04</classification-symbol><definition-title>containing only normal peptide links</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Peptides, and derivatives thereof, having up to four amino acids in a fully defined sequence and containing only normal peptide links.</paragraph-text></section-body></definition-statement><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Neutral amino acids</paragraph-text></table-column><table-column><paragraph-text type="body">have in their side chains the same number of amino groups and carboxylic acid groups or derivatives thereof, e.g. Gly</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Basic amino acids</paragraph-text></table-column><table-column><paragraph-text type="body">have in their side chains more amino groups than carboxylic acid groups or derivatives thereof, e.g. Arg, Lys</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Acidic amino acids</paragraph-text></table-column><table-column><paragraph-text type="body">have in their side chains more carboxylic acid groups or derivatives thereof than amino groups, e.g. Asp, Glu; Gln and Asn are also considered as acidic amino acids</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Aliphatic amino acids</paragraph-text></table-column><table-column><paragraph-text type="body">have only acyclic carbon atoms in their side chains, e.g. Ala</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Aromatic or cycloaliphatic amino acids</paragraph-text></table-column><table-column><paragraph-text type="body">have a carbocyclic in ring in their side chains, e.g. Phe</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Heterocyclic amino acids</paragraph-text></table-column><table-column><paragraph-text type="body">are amino acids wherein the side chain contains or is part of a heteroring, e.g. Pro, His, Trp</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Side chain</paragraph-text></table-column><table-column><paragraph-text type="body">the R radical in the optionally functionalised amino acid RCH(NH2)C O2H)</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">First amino acid</paragraph-text></table-column><table-column><paragraph-text type="body">means the N-terminal amino acid of the peptide sequence</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K5/0613</classification-symbol><definition-title>{Aspartame}</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Although <class-ref scheme="cpc">C07K5/00</class-ref>- <class-ref scheme="cpc">C07K5/126</class-ref> concern short peptides per se, there is one exception: methods for purification and preparation of aspartame are classified with aspartame in <class-ref scheme="cpc">C07K5/0613</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K5/12</classification-symbol><definition-title>Cyclic peptides {with only normal peptide bonds in the ring}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Peptides, and derivatives thereof, having up to four amino acids in a fully defined sequence in a cyclic form and containing only normal peptide bonds.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Cyclic peptides containing at least one abnormal peptide link </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K7/50</class-ref>- <class-ref scheme="cpc">C07K7/60</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Classify here only if cyclisation occurs via normal peptide links.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K7/00</classification-symbol><definition-title>Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><list><list-item><paragraph-text type="body">Oligomers of amino acids making up a sequence of between 5 and 20 residues in length containing at least one alpha peptide bond, which is also a normal peptide bond.</paragraph-text></list-item><list-item><paragraph-text type="body">Genes and nucleotide sequences coding for the above peptides.</paragraph-text></list-item><list-item><paragraph-text type="body">Crystals of the above peptides.</paragraph-text></list-item><list-item><paragraph-text type="body">Specific methods for the preparation of the above peptides.</paragraph-text></list-item></list><paragraph-text type="body">Peptides having 5 to 20 amino acids in a fully defined sequence and containing saccharide radicals are not covered by this group (see references relevant to classification below).</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Methods for the preparation of generic peptides (e.g. by chemical synthesis)</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K1/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Fragments of peptides included in this main group and having 4 or less amino acids </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K5/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides having 5 to 20 amino acids in a fully defined sequence and containing saccharide radicals</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K9/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Fragments of proteins should be classified with the parent polypeptide </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Fragments of immunoglobulins should be classified with the parent compound </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K16/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Fusion peptides are additionally classified in</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K2319/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides in foodstuff </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Pharmaceutical/dental/cosmetic/toilet uses and compositions of peptides that were already known at the time are classified in</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"> E.g. in one or more of the following:For dental, cosmetic and toilet indications:</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K6/00</class-ref> - <class-ref scheme="cpc">A61K8/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"> For pharmaceutical and medical purposes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K38/00</class-ref>, <class-ref scheme="cpc">A61K39/00</class-ref>, <class-ref scheme="cpc">A61K47/00</class-ref>, <class-ref scheme="cpc">A61K48/00</class-ref>, <class-ref scheme="cpc">A61K49/00</class-ref>, <class-ref scheme="cpc">A61K51/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Oligomers of amino acids with no normal peptide bond are classified with the organic compounds in the preceding</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Fragments of enzymes should be classified with the parent compound </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Documents in which the emphasis is laid on the method of preparation of fusion proteins may also be classified in</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/62</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Methods for the preparation of generic peptides (fermentative or enzyme-based procedures)</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12P21/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Investigation or analysis of peptides, including peptide sequencing, as well as diagnostic and/or analytical uses of peptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">In this main group, only the specific embodiments are classified. The generic definition of a group of peptides on the basis of structural variables, which may assume different values, e.g. a Markush formula, deserves no classification mark.</paragraph-text><paragraph-text type="body">In this main group, in the absence of any indication to the contrary, every specific embodiment is classified in the last appropriate place (last-place rule).</paragraph-text><paragraph-text type="body">As a consequence, one embodiment can only be associated with one classification mark within <class-ref scheme="cpc">C07K</class-ref>. A document disclosing a plurality of specific embodiments may be associated with one or more classification marks.</paragraph-text><paragraph-text type="body">Peptides modified by means of one or more of additions, deletions and substitutions of amino acids are classified as the parent peptide.</paragraph-text><paragraph-text type="body">As a corollary, fragments of peptides are classified with the parent peptides, which contain their sequences.</paragraph-text><paragraph-text type="body">The degree of structural homology is not particularly limited, as long as the origin of the fragment or the modified peptide is established on the basis of at least one function/activity in common with the parent peptide.</paragraph-text><paragraph-text type="body">Fusion peptides are classified in the classes of their components, and additionally in <class-ref scheme="cpc">C07K2319/00</class-ref>.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Amino acids</paragraph-text></table-column><table-column><paragraph-text type="body">Are compounds in which at least one amino group and at least one carboxyl group are bound to the same carbon skeleton and the nitrogen atom of the amino group may form part of a ring</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Normal peptide link</paragraph-text></table-column><table-column><paragraph-text type="body">Is one between an alpha-amino group of an amino acid and the alpha- carboxy group of another alpha-amino acid</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Abnormal peptide link</paragraph-text></table-column><table-column><paragraph-text type="body">Is a link where at least one of the linked amino acids is not an alpha-amino acid or a link formed by at least one carboxyl or amino group being part of the side chain of an alpha-amino acid</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides</paragraph-text></table-column><table-column><paragraph-text type="body">Are compounds containing at least two amino acid units, which are bound through at least one normal peptide link, including oligopeptides, polypeptides and proteins</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Linear peptides</paragraph-text></table-column><table-column><paragraph-text type="body">Are normal or abnormal peptides which may comprise rings formed through S-S bridges, or through a hydroxy or a mercapto group of an hydroxy -or mercaptoamino acid and the carboxyl group of another amino acid, (e.g. peptide lactones) but do not comprise rings which are formed only through peptide links</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Cyclic peptides</paragraph-text></table-column><table-column><paragraph-text type="body">Are peptides comprising at least one ring formed only through peptide links; the cyclisation may occur only through normal peptide links or through abnormal peptide links, e.g. through the 4-amino group of 2,4-diamino-butanoic acid. Cyclic compounds in which at least one link in the ring is a non-peptide link are considered as &quot;linear peptides&quot;</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Related peptide and peptide derivative</paragraph-text></table-column><table-column><paragraph-text type="body">It is intended a peptide, which retains at least one function/activity of the parent peptide.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Defined sequence and undefined sequence</paragraph-text></table-column><table-column><paragraph-text type="body">Are used here in order to characterize an intrinsic property of the peptide, and do not refer to the actual knowledge of the amino acid sequence, i.e. the adjective defined is not used here with the same meaning of determined. Peptides with a &quot;defined sequence&quot; have an unique amino acid sequence and are classified as such even if their amino acid sequence has not been disclosed and is not known. An &quot;undefined sequence&quot; means a degeneration of the sequence information, e.g. if the peptide is defined as a random sequence of various amino acids.</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K9/00</classification-symbol><definition-title>Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Peptides having up to 20 amino acids containing saccharide radicals and having a fully defined sequence and derivatives thereof. They must have at least one normal peptide link. The peptides classified above are often called glycopeptides and are defined as peptides of appropriate length (see <class-ref scheme="cpc">C07K7/00</class-ref>) possessing one or more glycoside groups on the side chain(s) of the constituting peptides.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K11/00</classification-symbol><definition-title>Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Depsipeptides having up to 20 amino acids in a fully defined sequence. Derivatives thereof.</paragraph-text></section-body></definition-statement><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Depsipeptides</paragraph-text></table-column><table-column><paragraph-text type="body">are compounds containing a sequence of at least two alpha-amino acids and at least one alpha-hydroxy carboxylic acid, which are bound through at least one normal peptide link and at least an ester link, derived from the hydroxy carboxylic acid.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Linear depsipeptides</paragraph-text></table-column><table-column><paragraph-text type="body">may comprise rings formed through S-S bridges, or through an hydroxy or a mercapto group of an hydroxy-or mercapto-amino acid and the carboxyl group of another amino- of hydroxy-acid, but do not comprise rings formed only through peptide or ester links derived from alpha-hydroxy carboxylic acids; e.g. Gly-Ala-Gly-OCH2CO2H and Gly-OCH2CO-Ala-Gly are considered as &quot;linear depsipeptides&quot;, but HOCH2CO-Gly-Ala-Gly does not contain an ester link, and is thus a derivative of Gly-Ala- Gly which is covered by <class-ref scheme="cpc">C07K5/08</class-ref>.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Cyclic depsipeptides</paragraph-text></table-column><table-column><paragraph-text type="body">are peptides containing at least one ring formed only through peptide or ester links derived from alpha-hydroxy carboxylic acids,e.g. cyclic Gly-Ala-Gly-OCH2CO. </paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item date-revised="2016-11-01"><classification-symbol scheme="cpc">C07K14/00</classification-symbol><definition-title>Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><list><list-item><paragraph-text type="body">Polymers of amino acids linked by peptide bonds, and compositions containing them.</paragraph-text></list-item><list-item><paragraph-text type="body">Genes and other polynucleotides coding for peptides.</paragraph-text></list-item><list-item><paragraph-text type="body">Non-coding nucleic acid sequences, e.g. promoters, operators, derived from genes or operons coding for peptides</paragraph-text></list-item><list-item><paragraph-text type="body">Fragments of peptides and nucleic acids encoding peptides (fragments smaller than 21 amino acids are classified with the parent peptides; fragments of 2-4 amino acid residues are also classified in <class-ref scheme="cpc">C07K5/00</class-ref></paragraph-text></list-item><list-item><paragraph-text type="body">Methods for preparation and purification of specific peptides are classified with these peptides. General methods are classified in <class-ref scheme="cpc">C07K1/00</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Fusion proteins</paragraph-text></list-item><list-item><paragraph-text type="body">Crystallized proteins</paragraph-text></list-item><list-item><paragraph-text type="body">Hybrid peptides (classified according to their peptide component)</paragraph-text></list-item></list></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">Medicinal preparations containing known peptides are not classified in <class-ref scheme="cpc">C07K</class-ref>, only in <class-ref scheme="cpc">A61K</class-ref>.</paragraph-text></section-body></relationship><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Peptides having less than 21 amino acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K4/00</class-ref>- <class-ref scheme="cpc">C07K7/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Proteins of humans and other mammals</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/47</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoglobulins</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K16/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Carrier-bound or immobilised peptides and preparation thereof</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K17/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><application-references><section-title>Application-oriented references</section-title><section-body><paragraph-text type="preamble">Examples of places where the subject matter of this place is covered when specially adapted, used for a particular purpose, or incorporated in a larger system:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Medicinal preparations containing peptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K38/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides with enzymatic activity</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref></paragraph-text></table-column></table-row></table></section-body></application-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Peptides in foodstuff</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Compositions for measuring or testing processes involving peptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Investigation or analysis of peptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/00</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">In this subclass, in the absence of an indication to the contrary, a compound is classified in the last appropriate place.</paragraph-text><paragraph-text type="body">Methods for the preparation or purification of specific peptides are classified in the group of the corresponding peptides. However, the invention may also be valid for other peptides and such documents are also classified in <class-ref scheme="cpc">C07K1/00</class-ref>.</paragraph-text><paragraph-text type="body">Fragments of peptides modified by removal or addition of amino acids, by substitution of amino acids by others, or by combination of these modifications are classified as the parent peptides. However, fragments of peptides having four or less amino acids are also classified in group <class-ref scheme="cpc">C07K5/00</class-ref>.</paragraph-text><paragraph-text type="body">Specific peptides prepared by chemical processes or peptides having an amino acid sequence derived from specific peptides are classified with the specific peptides.</paragraph-text><paragraph-text type="body">Protease inhibitors that are fragments of proteases are classified only in <class-ref scheme="cpc">C12N9/50</class-ref>-<class-ref scheme="cpc">C12N9/86</class-ref>, not in <class-ref scheme="cpc">C07K14/81</class-ref>.</paragraph-text><paragraph-text type="body">Peptides prepared by recombinant DNA technology are not classified according to the host, but according to the original peptide expressed, e.g. HIV peptide expressed in E. coli is classified with HIV peptides.</paragraph-text><paragraph-text type="body">Fusion peptides are classified in the classes of their components, the document has further to be given a class for fusion proteins: <class-ref scheme="cpc">C07K2319/00</class-ref></paragraph-text><paragraph-text type="body">Documents in which emphasis is given on the method for the preparation of fusion proteins are classified in <class-ref scheme="cpc">C12N15/62</class-ref>.</paragraph-text><paragraph-text type="body">Hybrid peptides are classified according to their peptide component.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Amino acid</paragraph-text></table-column><table-column><paragraph-text type="body">compounds in which at least one amine and at least one carboxylic group are bound to the same carbon skeleton and the nitrogen atom of the amino group may form a ring</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptide bond</paragraph-text></table-column><table-column><paragraph-text type="body">a link between an alpha-amino group of an amino acid and the carboxylic group &#8211; in position 1 &#8211; of another alpha-amino acid</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoglobulin </paragraph-text></table-column><table-column><paragraph-text type="body">protein produced by B cells, made up of two identical heavy and two identical light chains, held together by interchain disulfide bonds</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Hybrid peptide</paragraph-text></table-column><table-column><paragraph-text type="body">peptide comprising components of heterologous molecules</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Fusion peptide</paragraph-text></table-column><table-column><paragraph-text type="body">peptide consisting of (parts of) different proteins covalently linked to each other by a peptide bond </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Signal sequence</paragraph-text></table-column><table-column><paragraph-text type="body">a 3-60 amino acids stretch that directs the transport of the protein to which it is attached</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K14/001</classification-symbol><definition-title>{by chemical synthesis}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Preparation of proteins and peptides having more than 20 amino acids, and derivatives thereof, by chemical synthesis.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K14/003</classification-symbol><definition-title>{Peptide-nucleic acids (PNAs)}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Chemical synthesis of peptide-nucleic acids in which the peptide contains more than 20 amino acids.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K14/005</classification-symbol><definition-title>from viruses</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">New viral proteins or individual genes encoding said proteins, as well as new structural or functional aspects of known viral proteins or genes. Also fragments of said proteins or genes are covered.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">The subdivision corresponding to IPC <class-ref scheme="cpc">C07K14/01</class-ref> until <class-ref scheme="cpc">C07K14/19</class-ref> is no longer used, since the taxonomic division in this part of the IPC is incomplete and inconsistent with other parts of the classification relating to viruses.</paragraph-text><paragraph-text type="body">The viral proteins, genes and fragments as indicated above are to be classified using the codes in the <class-ref scheme="cpc">C12N2710/00</class-ref>-<class-ref scheme="cpc">C12N2795/00</class-ref> ranges combining taxonomic information with further aspects, whereby the specific ending 22 relates to aspects of individual viral proteins and their corresponding genes.</paragraph-text><paragraph-text type="body">Only if the main invention resides in the viral protein, individual gene or fragment thereof, <class-ref scheme="cpc">C07K14/005</class-ref> is to be given. No other EC class should be assigned.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2016-11-01"><classification-symbol scheme="cpc">C07K14/435</classification-symbol><definition-title>from animals; from humans</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><list><list-item><paragraph-text type="body">Polymers of amino acids linked by peptide bonds, and compositions containing them.</paragraph-text></list-item><list-item><paragraph-text type="body">Genes and other polynucleotides coding for peptides.</paragraph-text></list-item><list-item><paragraph-text type="body">Non-coding nucleic acid sequences, e.g. promoters, operators, derived from genes or operons coding for peptides</paragraph-text></list-item><list-item><paragraph-text type="body">Fragments of peptides and nucleic acids encoding peptides (fragments smaller than 21 amino acids are classified with the parent peptides; fragments of 2-4 amino acid residues are also classified in <class-ref scheme="cpc">C07K5/00</class-ref></paragraph-text></list-item><list-item><paragraph-text type="body">Methods for preparation and purification of specific peptides are classified with these peptides. General methods are classified in <class-ref scheme="cpc">C07K1/00</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Fusion proteins</paragraph-text></list-item><list-item><paragraph-text type="body">Crystallized proteins</paragraph-text></list-item><list-item><paragraph-text type="body">Hybrid peptides (classified according to their peptide component)</paragraph-text></list-item></list></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">Medicinal preparations containing known peptides are not classified in <class-ref scheme="cpc">C07K</class-ref>, only in <class-ref scheme="cpc">A61K</class-ref>.</paragraph-text></section-body></relationship><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Peptides having less than 21 amino acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K4/00</class-ref> - <class-ref scheme="cpc">C07K7/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Proteins of humans and other mammals</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/47</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoglobulins</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K16/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Carrier-bound or immobilised peptides and preparation thereof</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K17/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><application-references><section-title>Application-oriented references</section-title><section-body><paragraph-text type="preamble">Examples of places where the subject matter of this place is covered when specially adapted, used for a particular purpose, or incorporated in a larger system:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Medicinal preparations containing peptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K38/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides with enzymatic activity</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref></paragraph-text></table-column></table-row></table></section-body></application-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Peptides in foodstuff</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Compositions for measuring or testing processes involving peptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Investigation or analysis of peptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/00</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">In this subclass, in the absence of an indication to the contrary, a compound is classified in the last appropriate place.</paragraph-text><paragraph-text type="body">Methods for the preparation or purification of specific peptides are classified in the group of the corresponding peptides. However, the invention may also be valid for other peptides and such documents are also classified in <class-ref scheme="cpc">C07K1/00</class-ref>.</paragraph-text><paragraph-text type="body">Fragments of peptides modified by removal or addition of amino acids, by substitution of amino acids by others, or by combination of these modifications are classified as the parent peptides. However, fragments of peptides having four or less amino acids are also classified in group <class-ref scheme="cpc">C07K5/00</class-ref>.</paragraph-text><paragraph-text type="body">Specific peptides prepared by chemical processes or peptides having an amino acid sequence derived from specific peptides are classified with the specific peptides.</paragraph-text><paragraph-text type="body">Protease inhibitors that are fragments of proteases are classified only in <class-ref scheme="cpc">C12N9/50</class-ref>-<class-ref scheme="cpc">C12N9/86</class-ref>, not in <class-ref scheme="cpc">C07K14/81</class-ref>.</paragraph-text><paragraph-text type="body">Peptides prepared by recombinant DNA technology are not classified according to the host, but according to the original peptide expressed, e.g. HIV peptide expressed in E. coli is classified with HIV peptides.</paragraph-text><paragraph-text type="body">Fusion peptides are classified in the classes of their components, the document has further to be given a class for fusion proteins: <class-ref scheme="cpc">C07K2319/00</class-ref></paragraph-text><paragraph-text type="body">Documents in which emphasis is given on the method for the preparation of fusion proteins are classified in <class-ref scheme="cpc">C12N15/62</class-ref>.</paragraph-text><paragraph-text type="body">Hybrid peptides are classified according to their peptide component.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Amino acid</paragraph-text></table-column><table-column><paragraph-text type="body">compounds in which at least one amine and at least one carboxylic group are bound to the same carbon skeleton and the nitrogen atom of the amino group may form a ring</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptide bond</paragraph-text></table-column><table-column><paragraph-text type="body">a link between an alpha-amino group of an amino acid and the carboxylic group &#8211; in position 1 &#8211; of another alpha-amino acid</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoglobulin </paragraph-text></table-column><table-column><paragraph-text type="body">protein produced by B cells, made up of two identical heavy and two identical light chains, held together by interchain disulfide bonds</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Hybrid peptide</paragraph-text></table-column><table-column><paragraph-text type="body">peptide comprising components of heterologous molecules</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Fusion peptide</paragraph-text></table-column><table-column><paragraph-text type="body">peptide consisting of (parts of) different proteins covalently linked to each other by a peptide bond </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Signal sequence</paragraph-text></table-column><table-column><paragraph-text type="body">a 3-60 amino acids stretch that directs the transport of the protein to which it is attached</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item date-revised="2017-08-01"><classification-symbol scheme="cpc">C07K16/00</classification-symbol><definition-title>Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies {(antibodies with enzymatic activity, e.g. abzymes <class-ref scheme="cpc">C12N9/0002</class-ref>)}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Antibodies, immunoglobulins and proteins derived therefrom that bind a specific antigen, and have as minimal structural features an immunoglobulin framework and three CDRs (i.e. a variable domain). In addition, antibody mimetics and scaffolds that bind a specific antigen. Where appropriate, the term antibody as used in these definitions also encompasses said antigen-binding mimetics and scaffolds. The terms antibodies and immunoglobulins are often used interchangeably.</paragraph-text><paragraph-text type="body">This maingroup covers the following aspects of antibodies:</paragraph-text><paragraph-text type="body">Structure</paragraph-text><paragraph-text type="body">Production</paragraph-text><paragraph-text type="body">Specificity</paragraph-text><paragraph-text type="body">Cells producing the antibody, e.g. hybridomas producing a monoclonal antibody</paragraph-text><paragraph-text type="body">DNA/RNA encoding an antibody</paragraph-text><list><list-item><paragraph-text type="body">Therapeutic and prophylactic use</paragraph-text></list-item><list-item><paragraph-text type="body">Diagnostic use and use for detection</paragraph-text></list-item><list-item><paragraph-text type="body">Fusion proteins comprising at least the antigen-binding region of an antibody</paragraph-text></list-item></list><paragraph-text type="body">Antibody mimetics and scaffolds.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Fusion protein of an Fc-region of an immunoglobulin + a non-antibody protein</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K2319/30</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Stabilization of antibody compositions, e.g. for storage or administration</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K39/39591</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Antibody with enzymatic /catalytic activity, e.g. abzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/0002</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><application-references><section-title>Application-oriented references</section-title><section-body><paragraph-text type="preamble">Examples of places where the subject matter of this place is covered when specially adapted, used for a particular purpose, or incorporated in a larger system:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Medicinal preparations containing blood products</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K35/14</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Medicinal preparations containing peptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K38/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Medicinal preparations comprising a mixture of an antibody and a non-antibody</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K39/395</class-ref>, <class-ref scheme="cpc">A61K2300/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Stabilization of medicinal preparations comprising antibodies</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K39/39591</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Mixtures of active ingredients without chemical characterization</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K45/06</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Medicinal preparations comprising immunoconjugates</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K47/68</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Gene therapy</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K48/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Antibodies containing fluorescent labels for use in detection in vivo</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K49/0058</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Antibodies containing NMR labels for use in detection in vivo</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K49/16</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Antibodies containing radioactive substances for use in therapy or detection in vivo</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K51/10</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Antibodies with enzymatic activity</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/0002</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoassay; biospecific binding assay</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/53</class-ref></paragraph-text></table-column></table-row></table></section-body></application-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">General methods for the preparation of peptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K1/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides having more than 20 amino acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Medicinal preparations containing antigens </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K39/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Medicinal preparations comprising a mixture of an antibody and a non-antibody</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K39/395</class-ref>, <class-ref scheme="cpc">A61K2300/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Stabilization of medicinal preparations comprising antibodies</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K39/39591</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Medicinal preparations comprising immunoconjugates</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K47/68</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Antibodies containing fluorescent labels for use in detection in vivo</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K49/0058</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Antibodies containing NMR labels for use in detection in vivo</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K49/16</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Antibodies containing radioactive substances for use in therapy or detection in vivo</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K51/10</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Antibodies with enzymatic activity</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/0002</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoassay; biospecific binding assay</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/53</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">At least one group is mandatory. Additionally, one or more indexing codes may be given. Both the at least one group and the indexing code(s) are mandatory for relevant and sufficiently disclosed aspects, e.g. for aspects actually disclosed in examples and not just casually claimed or generally referred to in the description. With regard to the specificity of an antibody for an antigen, the &quot;last-place-rule&quot; does not apply.</paragraph-text><paragraph-text type="body">(1) Antibody and/or fragments or derivatives thereof, i.e. the product per se. Emphasis is on the antigen specificity of the antibody.</paragraph-text><paragraph-text type="body">NOTE: The specificity of an antibody for a certain antigen (with synonyms) may be found in the regularly updated &quot;keyword/classification index&quot; at the end of this section. </paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (classified according to specificity), see the following examples:</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/08</class-ref> (against material from viruses)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/081</class-ref> or subgroups thereof (against material from DNA viruses)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/10</class-ref> or subgroups thereof (against material from RNA viruses)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/12</class-ref> or subgroups thereof (against material from bacteria)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/14</class-ref> (against material from fungi, algae or lichens)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/16</class-ref> (against material from plants)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/16</class-ref> (against material from plants)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> (against material from animals or humans)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/20</class-ref> (against material from protozoa)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> (against growth factors)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> or subgroups thereof (against cytokines, lymphokines or interferons)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> (against hormones)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> or subgroups thereof (against receptors)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> or subgroups thereof (against tumor antigens)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/32</class-ref> (against translation products of oncogenes)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/34</class-ref> (against blood group antigens)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/36</class-ref> (against blood coagulation factors)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> (against protease inhibitors of peptide structure)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> (against protease inhibitors of peptide structure)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> (against enzymes)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/42</class-ref> or subgroups thereof (against immunoglobulins)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/44</class-ref> (against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, individual amino acid residues, phosphorylated residues)</paragraph-text></list-item></list><paragraph-text type="body">Note: If an antigen that, under &quot;normal/benign&quot; conditions, justifies a class for the specifically binding antibody in the <class-ref scheme="cpc">C07K16/08</class-ref> - <class-ref scheme="cpc">C07K16/28</class-ref> and <class-ref scheme="cpc">C07K16/34</class-ref>-<class-ref scheme="cpc">C07K16/44</class-ref> ranges, is disclosed to be (over)expressed under malignant conditions (e.g. in or on a tumor cell), then an additional antibody class in the <class-ref scheme="cpc">C07K16/30</class-ref> - <class-ref scheme="cpc">C07K16/32</class-ref> (i.e. antibodies against tumor, resp. oncogene antigens) ranges should be given.</paragraph-text><paragraph-text type="body">(2) Antibody or fragments or derivatives thereof. Emphasis is on a new technique of the construction of the immunoglobulin molecule or derivative thereof.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C07K16/00</class-ref> (general) or <class-ref scheme="cpc">C07K16/005</class-ref> (phage display)</paragraph-text><paragraph-text type="body">Optionally a group in <class-ref scheme="cpc">C07K16/00</class-ref>(for the specificity, if in an example)</paragraph-text><paragraph-text type="body">(3) DNA/RNA encoding an antibody or a fragment thereof.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref>(for the specificity)</paragraph-text><paragraph-text type="body">No Indexing Code used for the aspect of DNA/RNA.</paragraph-text><paragraph-text type="body">(4) Hybridoma producing a monoclonal antibody. Emphasis is on the antigen specificity of the monoclonal antibody.</paragraph-text><paragraph-text type="body"> A group in <class-ref scheme="cpc">C07K16/00</class-ref>(for the specificity)</paragraph-text><paragraph-text type="body">No Indexing Code used for aspect of hybridoma.</paragraph-text><paragraph-text type="body">(5) Hybridoma producing a monoclonal antibody. Emphasis is on the technique of producing the hybridoma.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C12N5/00</class-ref>(for the hybridoma cell) and/or</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C12N15/00</class-ref>(for the hybridoma technique)</paragraph-text><paragraph-text type="body">Optionally a group in <class-ref scheme="cpc">C07K16/00</class-ref>(for the specificity, if there is an example)</paragraph-text><paragraph-text type="body">(6) Fusion protein of (at least an antigen-binding part of) an antibody + a non-antibody protein. Not to be confused with &apos;synthebodies&apos;, see further below.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity of the antibody part)</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K14/00</class-ref> (for the non-antibody part)</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2319/00</class-ref> (fusion protein)</paragraph-text><paragraph-text type="body">(7) Fusion protein of an Fc-region of an immunoglobulin + a non-antibody protein.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K14/00</class-ref> (for the non-antibody part)</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2319/30</class-ref> (Fc fused to non-Ig)</paragraph-text><paragraph-text type="body">(8) Chemical conjugate of (at least an antigen-binding part of) an antibody + a toxin or drug.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity) and</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">A61K47/68</class-ref> or subgroups thereof (if the antibody contains a drug or toxin for use in therapy in vivo) and/or</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">A61K51/10</class-ref> or subgroups thereof (if the antibody contains a radioactive substance for use in therapy in vivo)</paragraph-text><paragraph-text type="body">(9) Chemical conjugate of (at least an antigen-binding part of) an antibody + a detectable label.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity) and</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">G01N33/53</class-ref> or subgroups thereof (if the antibody is for use in detection in vitro) and/or</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">A61K51/10</class-ref> or subgroups thereof (if the antibody contains a radioactive substance for use in detection in vivo) and/or</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">A61K49/0058</class-ref> (if the antibody contains a fluorescent label for use in detection in vivo) and/or</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">A61K49/16</class-ref> (if the antibody contains a nuclear magnetic resonance label for use in detection in vivo)</paragraph-text><paragraph-text type="body">(10) Therapeutic use of an antibody or a therapeutic composition comprising an antibody.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">A61K2039/505</class-ref> (therapeutic use of an antibody, but only if in an in vivo example (this includes pharmacokinetic studies). Note: Because at the date of classification it is not foreseeable how plausible an in vitro assay will be for the assessment of therapeutic effectiveness, in vitro examples, including those that make in vivo therapeutic effectiveness plausible, should be classified in the <class-ref scheme="cpc">C07K2317/70</class-ref> series, see below), and/or</paragraph-text><paragraph-text type="body">optionally Indexing Code <class-ref scheme="cpc">A61K2039/54</class-ref> (route of administration, but only if important), and/or</paragraph-text><paragraph-text type="body">optionally Indexing Code <class-ref scheme="cpc">A61K2039/545</class-ref> (dose, timing or administration schedule, but only if important), and/or</paragraph-text><paragraph-text type="body">optionally Indexing Code <class-ref scheme="cpc">A61K2039/57</class-ref> (type of response, e.g. TH1- or TH2-type T cell response).</paragraph-text><paragraph-text type="body">(11) Therapeutic use of a combination of two or more antibodies or a therapeutic composition comprising two or more antibodies. Said antibodies have an additive or synergistic effect, and the antibodies may be given as a mixture or consecutively. This should not to be confused with a mixture of an antibody with a non-antibody, see below.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity of the first antibody), and</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity of the second antibody), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">A61K2039/507</class-ref> (therapeutic use of an antibody combination. Note: said code may not only be given for an in vivo example, but also if shown in an in vitro example), and/or</paragraph-text><paragraph-text type="body">Optionally Indexing Code <class-ref scheme="cpc">A61K2039/54</class-ref> (route of administration, but only if important), and/or</paragraph-text><paragraph-text type="body">Optionally Indexing Code <class-ref scheme="cpc">A61K2039/545</class-ref> (dose, timing or administration schedule, but only if important), and/or</paragraph-text><paragraph-text type="body">Optionally Indexing Code <class-ref scheme="cpc">A61K2039/57</class-ref> (type of response, e.g. TH1- or TH2-type response).</paragraph-text><paragraph-text type="body">(12) Therapeutic combinations of antibodies (or fragments thereof) + non-antibody proteins, or compositions comprising these combinations.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">A61K39/395</class-ref> (or a subgroup thereof), <class-ref scheme="cpc">A61K2300/00</class-ref>; <class-ref scheme="cpc">A61K39/40</class-ref>, <class-ref scheme="cpc">A61K2300/00</class-ref> or <class-ref scheme="cpc">A61K39/42</class-ref>, <class-ref scheme="cpc">A61K2300/00</class-ref> as a Combination Set, and</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">A61K38/00</class-ref> (for the non-antibody protein)</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity).</paragraph-text><paragraph-text type="body">(13) Therapeutic combinations of antibodies (or fragments thereof) + structurally undefined (e.g. functionally defined) compounds, or compositions comprising these combinations.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">A61K39/395</class-ref> (or a subgroup thereof), <class-ref scheme="cpc">A61K2300/00</class-ref>; <class-ref scheme="cpc">A61K39/40</class-ref>, <class-ref scheme="cpc">A61K2300/00</class-ref> or <class-ref scheme="cpc">A61K39/42</class-ref>, <class-ref scheme="cpc">A61K2300/00</class-ref> as a Combination Set, and</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">A61K45/06</class-ref> (for the structurally undefined compound)</paragraph-text><paragraph-text type="body"> A group in <class-ref scheme="cpc">C07K16/00</class-ref>(for the specificity).</paragraph-text><paragraph-text type="body">(14) Therapeutic combinations of antibodies (or fragments thereof) + blood-derived cells, or compositions comprising these combinations.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">A61K39/395</class-ref> (or a subgroup thereof), <class-ref scheme="cpc">A61K2300/00</class-ref>; <class-ref scheme="cpc">A61K39/40</class-ref>, <class-ref scheme="cpc">A61K2300/00</class-ref> or <class-ref scheme="cpc">A61K39/42</class-ref>, <class-ref scheme="cpc">A61K2300/00</class-ref> as a Combination Set, and</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">A61K35/14</class-ref> (for the blood-derived cells)</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity).</paragraph-text><paragraph-text type="body">(15) Diagnostic use of an antibody, or a diagnostic composition comprising an antibody. Emphasis is on the antigen specificity, not on the assay technique.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity)</paragraph-text><paragraph-text type="body">No Indexing Code used for aspect of diagnosis.</paragraph-text><paragraph-text type="body">(16) Diagnostic use of an antibody, or a diagnostic composition comprising an antibody. Emphasis is on a new assay technique. The antigen specificity may not be crucial.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">G01N33/53</class-ref> or subgroups thereof.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity, if there is an example).</paragraph-text><paragraph-text type="body">(17) Antibody isolated from eggs. Emphasis is on the isolation technique, not on the antigen specificity.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C07K16/02</class-ref> (for the isolation technique from eggs), and</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity, if in an example)</paragraph-text><paragraph-text type="body">(18) Antibody isolated from eggs. Emphasis is on the antigen specificity, not on the technique of isolation.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/11</class-ref> (antibody isolated from eggs)</paragraph-text><paragraph-text type="body">(19) Antibody isolated from milk. Emphasis is on the isolation technique, not on the antigen specificity.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C07K16/04</class-ref> (for the isolation technique from milk), and</paragraph-text><paragraph-text type="body">Optionally a group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity, if in an example)</paragraph-text><paragraph-text type="body">(20) Antibody isolated from milk. Emphasis is on the antigen specificity, not on the technique of isolation.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/12</class-ref> (antibody isolated from milk)</paragraph-text><paragraph-text type="body">(21) Antibody isolated from serum. Emphasis is on the isolation technique, not on the antigen specificity.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C07K16/06</class-ref> (for the isolation technique from serum), and</paragraph-text><paragraph-text type="body">Optionally <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity, if in an example)</paragraph-text><paragraph-text type="body">Note: The term &quot;serum&quot; should be interpreted widely and includes blood and plasma as well. In practice, the subgroup <class-ref scheme="cpc">C07K16/065</class-ref> is used more often and relates to the purification (e.g. by chromatography, filtration) and fragmentation (e.g. by enzymatic digestion) of the immunoglobulin.</paragraph-text><paragraph-text type="body">(22) Antibody isolated from plants. Emphasis is on the antigen specificity, not on the technique of isolation.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref>(for the specificity), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/13</class-ref> (antibody isolated from plants)</paragraph-text><paragraph-text type="body">(23) Antibody characterized by their source of isolation or production. Emphasis is on the protein-expression technique, e.g. to improve yield, purity or glycosylation, e.g. by using specific host-cells, vectors, additives or culture conditions.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref>(for the specificity), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/14</class-ref> (source of isolation, production)</paragraph-text><paragraph-text type="body">(24) Antibody according to its taxonomic origin.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/20</class-ref> (general aspects of origin), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/21</class-ref> (fully primate or fully human, including fully human antibodies produced by transgenic animals, e.g. by Xenomouse&#174;), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/22</class-ref> (fully camelid), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/23</class-ref> (fully avian)</paragraph-text><paragraph-text type="body">(25) Antibody comprising immunoglobulin-regions, -domains or -residues from more than one species, e.g. chimeric, humanized or veneered antibody. Emphasis is on a new technique of construction, not on the antigen specificity.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C07K16/461</class-ref>&#8230;. (for the technique), and</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity, if in an example)</paragraph-text><paragraph-text type="body">(26) Antibody comprising immunoglobulin-regions, -domains or -residues from more than one species, e.g. chimeric, humanized or veneered antibody. Emphasis is on the antigen specificity, not on the technique of construction.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/24</class-ref> (chimeric, humanized, veneered antibody)</paragraph-text><paragraph-text type="body">(27) Antibody characterized by general aspects of specificity or valency.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref>(for the specificity), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/30</class-ref>.</paragraph-text><paragraph-text type="body">(28) Multispecific (i.e. including bispecific) antibody. Emphasis is on a new technique of construction, not on the antigen specificity.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C07K16/468</class-ref> or subgroup thereof (for the technique of bispecific antibodies), and</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the first specificity, if in an example), and</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the second specificity, if in an example), and</paragraph-text><paragraph-text type="body">Optionally a group in <class-ref scheme="cpc">C07K16/00</class-ref> (for any additional specificity, if in an example)</paragraph-text><paragraph-text type="body">(29) Multispecific (i.e. including bispecific) antibody. Emphasis is on the antigen specificity, not on the technique of construction.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the first specificity), and</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the second specificity), and</paragraph-text><paragraph-text type="body">Optionally, a group in <class-ref scheme="cpc">C07K16/00</class-ref> (for any additional specificity, if in an example), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/31</class-ref> (multispecific antibody)</paragraph-text><paragraph-text type="body">(30) Antibody specific for a neo-epitope formed by a complex, e.g. antibody-antigen, ligand-receptor. The antibody is monospecific, not bispecific !</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the first component of the complex), and</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref>(for the second component of the complex), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/32</class-ref> (to indicate specificity for the complex)</paragraph-text><paragraph-text type="body">(31) Antibody characterized by its crossreactivity (e.g. for species or epitope) or lack of crossreactivity.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/33</class-ref> (for the aspect of crossreactivity or explicit lack thereof).</paragraph-text><paragraph-text type="body">(32) Antibody characterized by its specificity for a well-defined epitope or immunogen which is either linear and shorter than 20 amino acid residues, or conformational and defined by amino acid residues.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity for the antigen), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/34</class-ref> (linear epitope &lt;20 AA residues or conformational epitope defined by AA residues)</paragraph-text><paragraph-text type="body">(33) Antibody characterized by its valency, and wherein the fact that the molecule is monovalent, bivalent or multivalent is an important feature.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/35</class-ref> (for the aspect of valency, but only if important).</paragraph-text><paragraph-text type="body">(34) Antibody characterized by its post-translational modification.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/40</class-ref> (for the aspect of post-translational modification).</paragraph-text><paragraph-text type="body">(35) Antibody wherein the presence, absence or modification by glycosylation, sialylization, fucosylation is an important feature.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/41</class-ref> (glycosylation, sialylization, fucosylation)</paragraph-text><paragraph-text type="body">(36) Antibody characterized by immunoglobulin fragments.The mere provision of an amino acid or nucleotide sequence is not enough to justify one or more of the following codes:</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C07K16/00</class-ref> (for the specificity of the antigen binding part), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/50</class-ref> (fragments in general), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/51</class-ref> (complete heavy chain or Fd fragment), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/515</class-ref> (complete light chain), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/52</class-ref> (Fc or constant region, isotype), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/522</class-ref> (CH1), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/524</class-ref> (CH2), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/526</class-ref> (CH3), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/528</class-ref> (CH4), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/53</class-ref> (hinge), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/54</class-ref> (F(ab&apos;)2), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/55</class-ref> (Fab or Fab&apos;), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/56</class-ref> (variable = Fv), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/565</class-ref> (CDR), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/567</class-ref> (framework = FR), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/569</class-ref> (single domain = sdAb or dAb)</paragraph-text><paragraph-text type="body">Note: The mere provision of an amino acid or nucleotide sequence per se of the above fragment is not enough to justify one or more of the above-mentioned indexing codes, unless said fragment is actually manufactured or modified.</paragraph-text><paragraph-text type="body">Note: If features of both CDRs (or individual residues therein) and FRs (or individual residues therein) are modified, then both the <class-ref scheme="cpc">C07K2317/565</class-ref> and <class-ref scheme="cpc">C07K2317/567</class-ref> codes should be given, and not the general <class-ref scheme="cpc">C07K2317/56</class-ref> code. The <class-ref scheme="cpc">C07K2317/56</class-ref> code should be given if the focus is on the intact VH and/or VL domain(s).</paragraph-text><paragraph-text type="body">Note: Indexing codes in the <class-ref scheme="cpc">C07K2317/522</class-ref>-<class-ref scheme="cpc">C07K2317/53</class-ref> series should only be given for features, e.g. modifications, concerning these specific domains; otherwise the <class-ref scheme="cpc">C07K2317/52</class-ref> code should be given. Said specific domains need not necessarily be in isolated form, but may be in the context of their immunoglobulin molecule or fragments thereof.</paragraph-text><paragraph-text type="body">(37) Antibody characterized by non-natural combinations of immunoglobulins or fragments.This includes fusion proteins and chemically linked immunoglobulins or their fragments. Excluded are chimeric, humanized or veneered antibodies (see above).</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref>(for the specificity), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/60</class-ref> (general aspects), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/622</class-ref> (single chain = scFv), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/624</class-ref> (disulfide stabilized variable = dsFv), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/626</class-ref> (diabody, triabody), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/64</class-ref> (comprising a combination of variable region and constant region components), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/66</class-ref> (comprising a swap of domains, e.g. CH3-CH2, VH-CL, VL-CH1).</paragraph-text><paragraph-text type="body">Optionally Indexing Code <class-ref scheme="cpc">C07K2319/00</class-ref> (if fusion protein)</paragraph-text><paragraph-text type="body">(38) Antibody characterized by an effect upon binding to a cell or to an antigen</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref>(for the specificity), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/71</class-ref> (decreased effector function due to an Fc-modification), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/72</class-ref> (increased effector function due to an Fc-modification), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/73</class-ref> (induction of cell death, e.g. apoptosis, necrosis; inhibition of cell proliferation), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/732</class-ref> (antibody-dependent cellular cytotoxicity (ADCC)), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/734</class-ref> (complement-dependent cytotoxicity (CDC)), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/74</class-ref> (induction of cell proliferation), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/75</class-ref> (agonist effect on antigen), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/76</class-ref> (antagonist effect on antigen, neutralization, inhibition of binding), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/77</class-ref> (internalization into the cell).</paragraph-text><paragraph-text type="body">(39) Antibody characterized by remaining in the (producing) cell, i.e. intracellular antibody = intrabody</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref>(for the specificity), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/80</class-ref> (general aspects), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/81</class-ref> (intracellular antibody functional in the ER or Golgi apparatus), and/or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/82</class-ref> (intracellular antibody functional in the cytoplasm, the nucleus, the mitochondria, the inner part of the cell membrane)</paragraph-text><paragraph-text type="body">(40) Antibody characterized by(pharmaco)kinetic aspects or stability of the immunoglobulin.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref>(for the specificity), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/90</class-ref> (general aspects), or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/92</class-ref> (for affinity (KD), association rate (Ka), dissociation rate (Kd), EC50 value), or</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2317/94</class-ref> (in vivo stability, e.g. half-life, pH-, temperature- or enzyme-resistance; Note: for in vitro/pretreatment storage stability see <class-ref scheme="cpc">A61K39/39591</class-ref>).</paragraph-text><paragraph-text type="body">(41) Antibody mimetics and scaffolds.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref>(for the specificity of the inserted antigen binding sequences from antibodies), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2318/00</class-ref> (general aspects of antibody mimetics and scaffolds)</paragraph-text><paragraph-text type="body">(42) Immunoglobulin or domain(s) thereof as scaffolds for inserted non-immunoglobulin peptide sequences, e.g. for vaccination purposes, e.g. synthebody.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref>(for the non-immunoglobulin protein that is inserted), and</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C07K16/00</class-ref>(for the specificity of the immunoglobulin scaffold), and</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2318/10</class-ref> (to indicate the combination of immunoglobulin scaffold molecules with inserted non-immunoglobulin peptide sequences)</paragraph-text><paragraph-text type="body">(43) Antigen-binding scaffold molecules wherein the scaffold is not an immunoglobulin variable region, antibody mimetics.</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K14/00</class-ref>(for the non-immunoglobulin protein that provides the scaffold).</paragraph-text><paragraph-text type="body">A group in <class-ref scheme="cpc">C07K16/00</class-ref>(for the antibody-like specificity of the scaffold molecule).</paragraph-text><paragraph-text type="body">Indexing Code <class-ref scheme="cpc">C07K2318/20</class-ref> (for scaffold molecules with antigen binding properties)</paragraph-text><paragraph-text type="body">Guide to the specificity of an antibody for a certain antigen (with synonyms) - KEYWORD/CLASSIFICATION INDEX (KCI)</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/08</class-ref> - Antigens from viruses</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/081</class-ref> - Antigens from DNA viruses</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/081</class-ref> - Antigens from orthopoxviridae</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/081</class-ref> - Antigens from vaccinia</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/082</class-ref> - Antigens from hepadnaviridae</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/082</class-ref> - Antigens from hepatitis B virus, HBV</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/084</class-ref> - Antigens from papovaviridae</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/084</class-ref> - Antigens from BK virus</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/084</class-ref> - Antigens from JC virus</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/084</class-ref> - Antigens from papillomavirus</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/084</class-ref> - Antigens from polyomavirus</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/084</class-ref> - Antigens from SV40</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/085</class-ref> - Antigens from herpetoviridae</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/085</class-ref> - Antigens from pseudorabies virus</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/085</class-ref> - Antigens from EBV, Epstein-Barr virus</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/087</class-ref> - Antigens from HSV, herpes simplex virus</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/088</class-ref> - Antigens from varicella-zoster virus</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/088</class-ref> - Antigens from CMV, cytomegalovirus</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/10</class-ref> - Antigens from RNA viruses</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/10</class-ref> - Antigens from hepatitis E virus, HEV</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/10</class-ref> - Antigens from corona virus</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/10</class-ref> - Antigens from SARS</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1009</class-ref> - Antigens from picornaviridae</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1009</class-ref> - Antigens from hepatitis A virus, HAV</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1018</class-ref> - Antigens from orthomyxoviridae</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1018</class-ref> - Antigens from influenza virus</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1027</class-ref> - Antigens from paramyxoviridae</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1027</class-ref> - Antigens from respiratory syncytial virus, RSV</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1036</class-ref> - Antigens from retroviridae</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1036</class-ref> - Antigens from leukemia viruses</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1045</class-ref> - Antigens from lentiviridae</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1045</class-ref> - Antigens from human immunodeficiency virus, HIV</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1045</class-ref> - Antigens from feline immunodeficiency virus, FIV</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1045</class-ref> - Antigens from simian immunodeficiency virus, SIV</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1054</class-ref> - Antigens from gag-pol</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1054</class-ref> - p17</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1054</class-ref> - p24</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1063</class-ref> - Antigens from env</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1063</class-ref> - gp41</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1063</class-ref> - gp110/120</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1063</class-ref> - gp160</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1063</class-ref> - V3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1063</class-ref> - PND</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1063</class-ref> - CD4-binding site</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1072</class-ref> - Antigens from regulatory proteins</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1072</class-ref> - tat</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1072</class-ref> - rev</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1072</class-ref> - vpt</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1081</class-ref> - Antigens from togaviridae</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1081</class-ref> - Antigens from flavivirus</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1081</class-ref> - Antigens from rubella virus</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1081</class-ref> - Antigens from hog cholera virus</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/109</class-ref> - Antigens from hepatitis C virus, HCV</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/109</class-ref> - Antigens from hepatitis G virus, HGV</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/12</class-ref> - Antigens from bacteria</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1203</class-ref> - Antigens from Gram-negative bacteria</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1203</class-ref> - LPS, lipopolysaccharide</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1207</class-ref> - Antigens from Spirochaetales</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1207</class-ref> - Antigens from Treponema</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1207</class-ref> - Antigens from Leptospira</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/121</class-ref> - Antigens from Helicobacter (Campylobacter)</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1214</class-ref> - Antigens from Pseudomonadaceae</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1217</class-ref> - Antigens from Neisseriaceae</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1217</class-ref> - Antigens from Acinetobacter</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1221</class-ref> - Antigens from Brucella</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1225</class-ref> - Antigens from Bordetella</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1228</class-ref> - Antigens from Enterobacteriaceae</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1228</class-ref> - Antigens from Citrobacter</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1228</class-ref> - Antigens from Serratia</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1228</class-ref> - Antigens from Proteus</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1228</class-ref> - Antigens from Providencia</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1228</class-ref> - Antigens from Morganella</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1228</class-ref> - Antigens from Yersinia</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1232</class-ref> - Antigens from Escherichia</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1235</class-ref> - Antigens from Salmonella</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1239</class-ref> - Antigens from Vibrionaceae</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1242</class-ref> - Antigens from Pasteurellaceae</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1242</class-ref> - Antigens from Haemophilus influenza</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1246</class-ref> - Antigens from Rickettsiales</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/125</class-ref> - Antigens from Chlamydiales</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1253</class-ref> - Antigens from Mycoplasmatales</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1253</class-ref> - Antigens from Pleuropneumonia-like organisms</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1257</class-ref> - Antigens from Bacteridaceae</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/126</class-ref> - Antigens from Legionella</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1264</class-ref> - Antigens from Rhizobiaceae</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1267</class-ref> - Antigens from Gram-positive bacteria</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1271</class-ref> - Antigens from Micrococcaceae</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1271</class-ref> - Antigens from Staphylococcus</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1271</class-ref> - Antigens from multi-resistant Staphylococcus aureus, MRSA</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1275</class-ref> - Antigens from Streptococcus</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1278</class-ref> - Antigens from Bacillus</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1282</class-ref> - Antigens from Clostridium</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1282</class-ref> - Botulinum neurotoxin A, BoNT/A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1282</class-ref> - Botulinum neurotoxin B, BoNT/B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1282</class-ref> - Botulinum neurotoxin C1, BoNT/C1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1282</class-ref> - Botulinum neurotoxin D, BoNT/D</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1282</class-ref> - Botulinum neurotoxin E, BoNT/E</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1282</class-ref> - Botulinum neurotoxin F, BoNT/F</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1282</class-ref> - Botulinum neurotoxin G, BoNT/G</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1282</class-ref> - SNAP-23, synaptosomal-associated protein of 23 kDa</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1282</class-ref> - SNAP-25, synaptosomal-associated protein of 25 kDa</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1282</class-ref> - TT, tetanus toxoid</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1285</class-ref> - from Corynebacterium</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1285</class-ref> - LLO, listeriolysin</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1289</class-ref> - Antigens from Mycobacteriaceae</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1292</class-ref> - Antigens from Actinomyces</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1292</class-ref> - Antigens from Streptomyces</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/1296</class-ref> - Antigens from Listeria</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/14</class-ref> - Antigens from fungi, algea or lichens</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/14</class-ref> - Streptavidin</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/16</class-ref> - Antigens from plants</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Antigens from animals or humans</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Acetylcholine</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Actin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - ADDL, beta amyloid oligomeric ligand</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Aggrecan</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Annexins</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Apolipoprotein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Avidin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Beta amyloid, Abeta, amyloid beta</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - CGRP, calcitonin gene-related peptide</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Collagen</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Complement</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - (Complement) factor B, fB</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - (Complement) factor D, fD</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Cyr61, Cyr-61, cystein-rich protein, GIG-1, IGFBP10, CCN1, insulin growth factor binding protein 10</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Desmin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - DKK-1, DKK1, Dickkopf 1, dickkopf homolog 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - DKK-2, DKK2, Dickkopf 2, dickkopf homolog 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - DKK-3, DKK3, Dickkopf 3, dickkopf homolog 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - DKK-4, DKK4, Dickkopf 4, dickkopf homolog 4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Dopamine</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Elastin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Endoplasmin, GRP94, Hsp90B1, ERp99</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Epinephrine, adrenaline (also in <class-ref scheme="cpc">C07K16/26</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein, FABP</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 1, FABP 1, FABP1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 2, FABP 2, FABP2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 3, FABP 3, FABP3 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 4, FABP 4, FABP4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 5, FABP 5, FABP5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 6, FABP 6, FABP6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 7, FABP 7, FABP7</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 8, FABP 8, FABP8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 9, FABP 9, FABP9</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 10, FABP 10, FABP10</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 11, FABP 11, FABP11</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 12, FABP 12, FABP12</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 5 like 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 5 like 2 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 5 like 3 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 5 like 4 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 5 like 5 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 5 like 6 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fatty acid binding protein 5 like 7 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Ferritin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fibrin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Fibronectin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - FispI2, fibroblast secreted protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Foxp3, SCURFIN</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - GAP43, GAP 43, growth associated protein 43, neuromodulin, protein F1, B-50, P57, PP46</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - GFAP, glial fibrillary acidic protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - GRP78, BiP, immunoglobulin binding protein, HSPA5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Heat shock proteins, HSP</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Heat shock cognate protein 71, HSC71</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Heparin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - HIG-1, hypoxia-induced gene</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Keratin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Laminin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Lipocalin, uterocalin, NGAL, LCN2, 24p3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Lipocortin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - LRG1, leucine rich alpha 2 glycoprotein 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - LDL, low density lipoprotein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - MCI, multicilin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - MCPH1, microcephalin 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - MD-2, myeloid differentiation protein 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - MIG6, MIG-6, RALT, ERRFI1, ErbB receptor feedback inhibitor 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Myosin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Nanog</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Neurotensin, NTS (also in <class-ref scheme="cpc">C07K16/26</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - NOD2, CARD-15, IBD1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Norepinephrine, noradrenaline</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - NuIP, Nurr1-interacting protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - OLFM1, olfactomedin 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - OLFM2, olfactomedin 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - OLFM3, olfactomedin 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - OLFML2b, olfactomedin-like 2b</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - OLFML3, olfactomedin-like 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Osteocalcin, bone gla protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Osteonectin, SPARC, secreted protein acidic and rich in cysteines, BM-40, BM40, basement membrane protein 40</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Ovalbumin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Ovotransferrin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - OxLDL, oxidized low density lipoprotein, oxidized LDL</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - PAMG-1, placental alpha microglobulin 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Perforin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Periostin, POSTN, OSF2, OSF-2, osteoblast-specific factor 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Properdin, factor P</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Properdin, factor P</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - PYY, YY protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - SAP, SLAM-associated protein, serum amyloid protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - SATB2, special AT-rich sequence binding protein 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - SFRP2, secreted frizzled-related protein 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - SFRP5, secreted frizzled-related protein 5, SARP3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Shh, sonic hedgehog homolog</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - SIP, sphingosine 1 phosphate</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - SLIT1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - SLIT2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Soggy</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Spadin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - SSEA-3, stage-specific embryonic antigen 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - SSEA-4, stage-specific embryonic antigen 4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - SRF, serum response factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - SUMO1, SUMO-1, small ubiquitin-like modifier 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - SUMO2, SUMO-2, small ubiquitin-like modifier 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - SUMO3, SUMO-3, small ubiquitin-like modifier 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - SUMO4, SUMO-4, small ubiquitin-like modifier 4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Synuclein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Tenascin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Transferrin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Troponin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - TTR, transthyretin, CTS, CTS1, PALB, TBPA</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Ubiquitin, APF-1, ATP-dependent proteolysis factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Uromodulin, Tamm-Horsfall protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Versican, VCAN</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Vimentin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/18</class-ref> - Vitronectin</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/20</class-ref> - Antigens from protozoa </paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/205</class-ref> - Antigens from Plasmodium</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/205</class-ref> - TRAP, thrombospondin-related adhesion molecule </paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Growth factors, growth regulators</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Activin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Activin A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Activin B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Activin C</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Activin D</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Activin E</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Adrenomedullin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Angiogenin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Angiopoietin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Angiopoietin 1, Ang-1, Angpt-1, Ang1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Angiopoietin 2, Ang-2, Angpt-2, Ang2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Angiopoietin 3, Ang-3, Angpt-3, Ang3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Angiopoietin 4, Ang-4, Angpt-4, Ang4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Angiopoietin-like protein 2, Angptl-2, ARP2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Angiopoietin-like protein 3, Angptl-3, ARP3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Angiopoietin-like protein 4, Angptl-4, PGAR, BK89, FIAF, fasting- induced adipose factor, HFARP, hepatic fibrinogen/angiopoietin-related protein, FDRG, fibrinogen-domain, TANGO115, PPARgamma, peroxisome proliferator-activated angiopoietin-related gamma </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Angiopoietin-like protein 5, Angptl-5, ARP5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Angiopoietin-like protein 6, Angptl-6, ARP6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Angiopoietin-like protein 7, Angptl-7, ARP7</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - ARIA</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Artemin, ARTN</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - BDNF, brain-derived neurotrophic factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - bone-inducing factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - bone morphogenetic factor, bone morphogenetic protein, BMP, morphogen </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - ChM-I, ChM-1, chondromodulin 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - CTGF, connective tissue growth factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - CTGF-1, connective tissue growth factor 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - CTGF-2, connective tissue growth factor 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Desert hedgehog, Dhh</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - EGF, epidermal growth factor, urogastrone</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - EGFL7, EGF-like domain multiple 7, EGF like domain 7, Neu1, Zneu1, VE-statin, vascular endothelial statin, RP11-25M1.2, epidermal growth factor like domain 7 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Epiregulin, ER, EREG</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - EPO, erythropoietin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - FGF, fibroblast growth factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - FGF-1, fibroblast growth factor 1, acidic FGF, aFGF, acidic fibroblast growth factor, retinal-derived growth factor, prostatropin, heparin- binding growth factor alpha, HBGF-alpha, eye-derived growth factor 2, ECGF, endothelial cell growth factor, brain-derived growth factor, astroglial growth factor 1, delta-15 beta endothelial growth factor, HBGF-1, heparin-binding growth factor 1 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - FGF-2, fibroblast growth factor 2, basic FGF, bFGF, basic fibroblast growth factor, macrophage growth factor, hepatoma-derived growth factor, heparin-binding growth factor beta, eye-derived growth factor 1, chondrosarcoma-derived growth factor, cartilage-derived growth factor, astroglial growth factor 2 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - FGF-3, fibroblast growth factor 3, INT-2 oncogene</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - FGF-4, fibroblast growth factor 4, heparin-binding secretory transforming factor, HST-1, human transforming protein, HST, human Kaposi sarcoma oncogene </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - FGF-5, fibroblast growth factor 5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - FGF-6, fibroblast growth factor 6, HST-2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - FGF-7, fibroblast growth factor 7, SDGF-3, spleen-derived growth factor 3, HBGF-7, heparin-binding growth factor 7 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - FGF-8, fibroblast growth factor 8, AIGF, androgen-induced growth factor </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - FGF-9, fibroblast growth factor 9, GAF, glia activating factor </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - FGF-10, fibroblast growth factor 10</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - FGF-11, fibroblast growth factor 11, FHF-1, FGF homologous factor 1, fibroblast growth factor homologous factor 1 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - FGF-12, fibroblast growth factor 12, FHF-2, FGF homologous factor 2, fibroblast growth factor homologous factor 2, KGF-2, keratinocyte growth factor 2 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - FGF-13, fibroblast growth factor 13, FHF-3, FGF homologous factor 3, fibroblast growth factor homologous factor 3 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - FGF-14, fibroblast growth factor 14, FHF-4, FGF homologous factor 4, fibroblast growth factor homologous factor 4 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - FGF-15, fibroblast growth factor 15</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - FGF-CX, fibroblast growth factor CX</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Fibulin 5, FBLN-5, DANCE, EVEC</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - GDF-8, growth and differentiation factor 8, myostatin, mstn </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - GDF-15, growth and differentiation factor 15, MIC-1, macrophage inhibitory cytokine 1, PDF, prostate-derived factor, PLAB, placental bone morphogenetic protein </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - GDNF, glial-derived neurotrophic factor, glial cell-derived neurotrophic factor </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Glial growth factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - HB-EGF, heparin-binding EGF-like growth factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - HBGF-2, heparin-binding growth factor 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Hedgehog, Hh</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Heregulin, HRG, Neu differentiation factor, NDF</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Heregulin alpha, HRG-alpha, </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Heregulin beta1, HRG-beta1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Heregulin beta2, HRG-beta2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Heregulin beta2-like, HRG-beta2-like</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Heregulin gamma, HRG-gamma</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Indian hedgehog, Ihh</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Insulin-like growth factors, IGF, somatomedins</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Insulin-like growth factor 1, IGF-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Insulin-like growth factor 2, IGF-2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - HGF, hepatocyte growth factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - MK, midkine, amphiregulin associated protein, ARAP, NEGF2, neurite growth promoting factor 2, neurite outgrowth promoting factor 2, neurite outgrowth promoting protein. </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - MSP, macrophage stimulating protein, HGFL, hepatocyte growth factor- like, MST-1 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Netrin 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Netrin 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Netrin 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Netrin 4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - neuregulin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - NGF, nerve growth factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - NOGO</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - NT-3, neurotrophin 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - NT-4/5, neurotrophin 4/5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - neurturin, NTN, NRTN</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - osteogenin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - PCDGF, PC cell derived growth factor, epithelin/granulin precursor, gp88 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Persephin, PSN, PSPN</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - PDGF, platelet derived growth factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - PDGF-A, platelet derived growth factor A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - PDGF-B, platelet derived growth factor B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - PDGF-C, platelet derived growth factor C, VEGF-R, zVEGF3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - PDGF-D, platelet derived growth factor D</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - PlGF, placental growth factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Prokineticin 1, pk1, prok1, EG-VEGF, endocrinal gland-derived vascular endothelial growth factor </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Prokineticin 2, pk2, prok2, bv8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - RGM, repulsive guidance molecule</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - RGM-A, repulsive guidance molecule A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - RGM-B, repulsive guidance molecule B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - RGM-C, repulsive guidance molecule C</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Sclerostin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - SKCG-1, SKCG1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Sonic hedgehog, Shh</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - TGF, transforming growth factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - TGFalpha, TGF alpha, transforming growth factor alpha, TGFa</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - TGFbeta, TGF beta, transforming growth factor beta, TGFb</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - VEGF, vascular endothelial growth factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - VEGF-C, vascular endothelial growth factor C, Flt4 ligand, Flt4-L</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - VRP, VEGF-related protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - WISP-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - WISP-2 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - WISP-3 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Wnt1, wnt-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Wnt2, wnt-2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Wnt3, wnt-3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Wnt5A, wnt-5A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Wnt7A, wnt-7A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Wnt7B, wnt-7B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Wnt8B, wnt-8B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Wnt10B, wnt-10B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Wnt11, wnt-11</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/22</class-ref> - Wntx, wnt-x</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - Cytokines, lymphokines, chemokines, interferons</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - Calgranulin A, MRP8, S100A8, calcium binding protein A8, CABP-P8, 60B8-B, cystic fibrosis antigen </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - Calgranulin B, MRP14, S100A9, calcium binding protein A9</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CXCL1, GROalpha, GRO-alpha, growth-related oncogene alpha, MGSAalpha, MGSA-alpha, melanoma growth stimulatory activity alpha, NAP-3, neutrophil-activating peptide 3, Gro-1 alpha </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CXCL2, GRObeta, GRO-beta, growth-related oncogene beta, MGSAbeta, MGSA-beta, melanoma growth stimulatory activity beta, MIP-2 alpha, macrophage inflammatory protein 2 alpha, Gro-1 beta </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CXCL3, GROgamma, GRO-gamma, growth-related oncogene gamma, MGSAgamma, MGSA-gamma, melanoma growth stimulatory activity gamma, MIP-2 beta, macrophage inhibitory protein 2 beta, Gro-1 gamma </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CXCL4, PF4, plasma factor 4, oncostatin A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CXCL5, ENA-78, epithelial cell-derived neutrophil attractant 78</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CXCL6, GCP-2, granulocyte chemotactic peptide 2, LPS-induced CXC, LIX </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CXCL7, NAP-2, neutrophil-activating protein 2, CTAP-3, connective tissue activating protein 3, LA-PF4, low affinity platelet factor 4, PBP, platelet basic protein, beta thromboglobulin </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CXCL9, Mig, monokine induced by IFN-gamma, CRG-10, cytokine responsive gene 10 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CXCL10, IP-10, interferon-inducible protein 10, immune protein 10, CRG-2, cytokine responsive gene 2 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CXCL11, I-TAC, interferon-inducible T cell alpha chemoattractant, IP-9, interferon-gamma inducible protein 9 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CXCL12, SDF-1, stromal cell-derived factor 1, PBSF, pre-B cell growth stimulating factor </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CXCL13, BLC, B lymphocyte chemoattractant, BCA-1, B cell attracting chemokine 1 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CXCL14, BRAK, CXC chemokine in breast and kidney, BMAC, B cell and monocyte activating chemokine, bolekine </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CXCL15, WECHE, weird chemokine</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL1, I-309, TCA-3, p500</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL2, MCP-1, monocyte chemoattractant protein 1, MCAF, monocyte chemoattractant and activating factor, GDCF, glioma cell-derived chemotactic factor, tumor necrosis factor-stimulated gene sequence 8, monocyte chemotactic protein 1 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL3, MIP-1alpha, MIP-1 alpha, macrophage inflammatory protein 1alpha, macrophage inflammatory protein 1 alpha, GOS-19, G0/G1 switch gene </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL4, MIP-1beta, MIP-1 beta, macrophage inflammatory protein 1beta, macrophage inflammatory protein 1 beta, ACT-2, immune activation gene 2 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL5, RANTES, regulated upon activation normal T cell expressed and secreted, EoCP-1, eosinophil chemotactic polipeptide 1, SIS-delta, small inducible secreted chemokine delta </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL6, C10, MRP-1, macrophage inflammatory protein-related protein 1 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL7, MCP-3, monocyte chemoattractant protein 3, MARC, mast cell activation-related chemokine, NC28 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL8, MCP-2, monocyte chemoattractant protein 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL9, MIP-1gamma, MIP-1 gamma, macrophage inflammatory protein 1gamma, macrophage inflammatory protein 1 gamma, CCF18 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL10</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL11, eotaxin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL12, MCP-5, monocyte chemotactic protein 5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL13, MCP-4, monocyte chemotactic protein 4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL14, HCC-1, hemofiltrate CC chemokine 1, M-CIF, macrophage colony inhibitory factor </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL15, MIP-5, macrophage inflammatory protein 5, HCC-2, hemofiltrate CC chemokine 2, NCC-3, leukotactin 1 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL16, LEC, NCC-4, HCC-4, hemofiltrate CC chemokine 4, new CC chemokine 4, liver-expressed chemokine, monotactin 1 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL17, TARC, ABCD-2, thymus and activation-regulated cytokine</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL18, DC-CK1, PARC, AMAC-1, dendritic cell-derived chemokine 1, pulmonary and activation-regulated chemokine, alternative activated macrophage-associated CC chemokine </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL19, ELC, exodus-3, EBI-1 ligand chemokine</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL20, LARC, exodus-1, liver and activation-regulated chemokine</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL21, SLC, exodus-2, 6Ckine, secondary lymphoid tissue chemokine</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL22, MDC, STCP-1, DC/B-CK, macrophage-derived chemokine, stimulated T cell chemoattractant protein 1 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL23, MPIF-1, myeloid progenitor inhibitory factor 1, chemokine beta8, chemokine beta 8 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL24, MPIF-2, eotaxin-2, myeloid progenitor inhibitory factor 2, chemokine beta6, chemokine beta 6 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL25, TECK, thymus-expressed chemokine</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL26, MIP-4alpha, MIP-4 alpha, TSC-1, eotaxin-3, macrophage inflammatory protein 4alpha, macrophage inflammatory protein 4 alpha, thymic stroma chemokine 1 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL27, CTACK, MILC, ILC, cutaneous T cell attracting chemokine, ALP, skinkine, eskine </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL28, MEC, mucosa-associated epithelial chemokine</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CCL3-L1, MIP-1alphaP, MIP1AP, LD78beta</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - Chemerin, RARRES2, RARRES-2, retinoic acid receptor responder 2, TIG2, TIG-2, tazarotene induced gene 2 product </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CK alpha 5, CKalpha-5, chemokine alpha 5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - CK alpha 6, CKalpha-6, chemokine alpha 6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - endokine alpha</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - HMGB1, high mobility group box protein 1, HMG-1, high mobility group protein 1 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - HMGB2, high mobility group box protein 2, HMG-2, high mobility group protein 2 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - HMGB3, high mobility group box protein 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - HMGB8, high mobility group box protein 8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - HMGB17, high mobility group box protein 17 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - HMGBI, high mobility group box protein I</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - HMGBY, high mobility group box protein Y </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - HMGBI(Y), high mobility group box protein I(Y) </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - HMGBI-C, high mobility group box protein I-C</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - IRAP, interleukin receptor antagonist protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - Limitin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - MIF, MMIF, macrophage migration inhibitory factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - OPN, osteopontin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - SCF, stem cell factor, c-kit ligand</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - SMAF1, SMAF-1, suppressive macrophage activation factor 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - SMAF2, SMAF-2, suppressive macrophage activation factor 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - thrombopoietin, TPO, MPL ligand</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - WSX</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - XCL1, lymphotactin, Ltn, Lptn, SCM-1alpha, SCM-1 alpha, single C motif 1alpha, ATAC, activation-induced T cell-derived and chemokine related </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - XCL2, SCM-1beta, SCM-1 beta, single C motif 1beta</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - zalpha11 ligand</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/24</class-ref> - Zcyto10</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/241</class-ref> - TNF, tumor necrosis factor, tumour necrosis factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/241</class-ref> - CD250, TNFalpha, TNF alpha, tumor necrosis factor alpha, tumour necrosis factor alpha, cachectin, TNFSF2, tumor necrosis factor (ligand) superfamily member 2 </paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/242</class-ref> - TNFbeta, TNF beta, tumor necrosis factor beta, tumour necrosis factor beta, LTalpha, LT alpha, lymphotoxin alpha, TNFSF1, tumor necrosis factor (ligand) superfamily member 1 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/242</class-ref> - LTbeta, LT beta, lymphotoxin beta, p33, TNFC, TNFSF3, tumor necrosis factor (ligand) superfamily member 3 </paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/243</class-ref> - CSF, colony stimulating factors</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/243</class-ref> - G-CSF, granulocyte colony stimulating factor, granulocyte CSF, CSF3, CSF-3 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/243</class-ref> - GM-CSF, granulocyte-macrophage colony stimulating factor, granulocyte-macrophage CSF. </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/243</class-ref> - M-CSF, macrophage colony stimulating factor, macrophage CSF, CSF1, CSF-1 </paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL, interleukin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-3, interleukin-3, HCGF, MCGF, multi-SCF</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-5, interleukin-5, BCGF-2, BCDF, Eo-CSF</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-7, interleukin-7, PBGF, LP-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-8, interleukin-8, CXCL8, NAP-1, neutrophil activating protein 1, NAF, neutrophil-activating factor, LAI, leukocyte adhesion inhibitor, GCP, granulocyte chemotactic protein, ENAP-beta, endothelial cell neutrophil-activating peptide </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-9, interleukin-9, MCGF</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-10, interleukin-10, CSIF, TGIF</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-11, interleukin-11, megakaryocyte CSF</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-12, interleukin-12, p40p35</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-12A, interleukin-12A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-12B, interleukin-12B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-13, interleukin-13, NC30, p600</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-14, interleukin-14, HMW-BCGF, high-molecular weight B cell growth factor, 60K-BCGF, Namalwa BCGF </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-15, interleukin-15, IL-T</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-16, interleukin-16, LCF, lymphocyte chemoattractant factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-17, interleukin-17, CTLA-8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-17B, interleukin-17B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-17C, interleukin-17C</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-17D, interleukin-17D</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-17E, interleukin-17E</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-17F, interleukin-17F</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-18, interleukin-18, IGIF, IFN-gamma inducing factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-19, interleukin-19</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-20, interleukin-20, zcyto10</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-21, interleukin-21</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-22, interleukin-22, IL-TIF, IL-10 related T cell derived inducible factor </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-23, interleukin-23, p19p40</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-23 p19 subunit, IL-B30</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> IL-24, interleukin-24, ST16, suppression of tumorigenicity 16, MDA- 7, melanoma differentiation associated gene 7, mob-5 (rat), c49a (rat), FISP (mouse) </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-25, interleukin-25, SF20</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-26, interleukin-26, AK155, ML-1 (?)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-27, interleukin-27, EBI3, Epstein-Barr virus-induced gene 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-28A, interleukin-28A, IFN lambda 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-28B, interleukin 28B, IFN lambda 2 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-29, interleukin-29, IFN lambda 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-30, interleukin-30, p28</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-31, interleukin-31</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-32, interleukin-32, NK4, TAIF</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-33, interleukin-33, IL-100, interleukin-100</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - IL-50, interleukin-50, TSLP, thymic stromal lymphopoietin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/244</class-ref> - LIF, leukemia inhibitory factor, myeloid differentiation stimulating factor, MDSF, cholinergic differentiation factor, D factor, emfilermin, AM424, AMRAD </paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/245</class-ref> - IL-1, interleukin-1, APPIF, adherence-promoting factor, acute phase protein inducing factor, BCDF, B cell differentiation factor </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/245</class-ref> - IL-1alpha, LAF, MCF, IL-1a</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/245</class-ref> - IL-1beta, IFN-beta-inducing factor, OAF, catabolin, IL-1b</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/246</class-ref> - IL-2, interleukin-2, T cell growth factor, blastogenic factor, LMF, lymphocyte mitogenic factor, LPF, lymphocyte proliferation factor, SCIF, secondary cytotoxic T cell inducing factor, TDF, thymocyte differentiation factor, TMF, thymocyte mitogenic factor, T cell maturation factor, T cell mitogenic factor, TSF, thymocyte stimulation factor </paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/247</class-ref> - IL-4, interleukin-4, IaIF, (MHC class II) Ia inducing factor, BCDF epsilon, BCDF gamma, B cell differentiation factor epsilon, B cell differentiation factor gamma, BCGF gamma, B cell growth factor gamma, BCGF-1, B cell growth factor 1, BSF-1, B cell stimulating factor 1, HCGF, Hodgkin&apos;s cell growth factor, IgE-EF, IgE enhancing factor, IgG1 enhancing factor, LMW-BCGF, low molecular weight B cell growth factor, MCGF-2, mast cell growth factor 2, MFF, macrophage fusion factor, TCGF-1, T cell growth factor 2 </paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/248</class-ref> - IL-6, interleukin-6, 26 kD protein, BCDF, B cell differentiation factor, BCSF, B cell stimulating factor, BSF-2, B cell stimulating factor 2, CDF, cytotoxic T cell differentiation factor, CPA, CSF-309, DIF, FDGI, FSF, fibronectin stimulating factor, HGF, hybridoma growth factor, HGI, HPGF, HSF, hepatocyte stimulating factor, IFNbeta2, IFN beta 2, interferon beta 2, ILHP1, L-HGF, MGI-2A, MGF, myeloma growth factor, NKAF, natural killer cell activating factor, PCTGF, plasmacytoma growth factor, TAF, T cell activating factor, thymocyte growth factor, TSF, thymocyte stimulating factor </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/248</class-ref> - OSM, oncostatin</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/249</class-ref> - IFN, interferons</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/249</class-ref> - IFNalpha, IFN-alpha, interferon alpha, alpha interferon, IFNa</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/249</class-ref> - IFNbeta, IFN-beta, interferon beta, beta interferon, IFNb</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/249</class-ref> - IFNgamma, IFN-gamma, interferon gamma, gamma interferon, IFNg </paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Hormones, neuropeptides</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Adiponectin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Alarin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Angiotensin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Anti-M&#252;llerian hormone, AMH, M&#252;llerian inhibiting factor, MIF, M&#252;llerian inhibiting hormone, MIH, M&#252;llerian inhibiting substance, MIS </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Apelin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Atrial natriuretic factor complex</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Atriopeptin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Atrial natriuretic peptide, ANP, natriuretic peptide type A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Brain natriuretic peptide, BNP, natriuretic peptide type B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Bombesin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Calcitonins</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Calcitonin gene-related peptide</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Cardionatrin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Cardiodilatin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Cholecystokinins, CCK</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Chorionic gonadotropins, HCG</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Chorionic somatomammotropin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Corticotropin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Corticotropin releasing factor, CRF, urotensin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - C-type natriuretic peptide, CNP, natriuretic peptide type C</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Endorphins</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Endothelin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Enkephalins</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Epinephrine, adrenaline (also in <class-ref scheme="cpc">C07K16/18</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Follicle-stimulating hormone, FSH</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Galanin, GAL</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Galanin-like peptide, GALP</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Gastrins</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Gastrin releasing peptide</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Ghrelin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - GIP, gastric inhibitory polypeptide, glucose-dependent insulinotropic polypeptide </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Glucagon</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - GLP-1, glucagon-like peptide 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - GLP-2, glucagon-like peptide 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Growth hormones, GH, somatotropin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Growth hormone releasing factors, GHRF</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Hepcidin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Insulins</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Leptin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Lipotropins</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Luteinising hormone, LH</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Melanocyte stimulating hormone, MSH</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Melanotropin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Motilins</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Neurotensin, NTS (also in <class-ref scheme="cpc">C07K16/18</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Orphan glycoprotein hormone, OGH</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Parathyroid hormone, parathormone</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Parathyroid hormone related peptides</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Prolactin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Prostaglandins</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Prostaglandin E2, PGE2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Relaxins</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Salusin alpha</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Salusin beta</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Secretins</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Serotonin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Somatostatins</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Substance P</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - TFF1, TFF-1, trefoil factor 1, trefoil factor family 1, BCEI, PS2, D21S21, HP1-A, PNR2, breast cancer estrogen-inducible protein, breast cancer estrogen-inducible sequence </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - TFF2, TFF-2, trefoil factor 2, trefoil factor family 2, AML1, spasmolysin, spasmolytic polypeptide, human spasmolytic polypeptide </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - TFF3, TFF-3, trefoil factor 3, ITF, intestinal trefoil factor, HITF, human intestinal trefoil factor, trefoil factor family 3 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Thymopoietins</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Thymosin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Thyroid stimulating hormone, TSH</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Vasoactive intestinal contractor, VIC</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Vasoactive intestinal peptide, VIP</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - Vasopressin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - zalpha48</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/26</class-ref> - zsig57</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - cell surface receptors/determinants/molecules</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - ARMP, Alheimer-related membrane protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Beclin-1, BECN1, BECN-1, protein GT197, ATG6, ATG-6, coiled-coil myosin-like BCL2-interacting protein, autophagy related gene 6 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CAP1, CAP-1, adenylyl cyclase-associated protein 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CAP2, CAP-2, adenylyl cyclase-associated protein 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Caprin-1, caprin1, M11S1, RNF105, p137GPI, GPIAP1, GPIp137</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Caveolin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Cav1, cav-1, caveolin 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Cav2, cav 2, caveolin 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Cav3, cav 3, caveolin 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CLASP-1, cadherin-like asymmetry protein 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CLASP-2, cadherin-like asymmetry protein 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CLASP-3, cadherin-like asymmetry protein 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CLASP-4, cadherin-like asymmetry protein 4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CLASP-5, cadherin-like asymmetry protein 5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CLASP-6, cadherin-like asymmetry protein 6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CLDN1, claudin-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CLDN2, claudin-2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CLDN3, claudin-3, RVP1, RVP-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CLDN4, claudin-4, Clostridium perfringens enterotoxin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CLDN5, claudin-5, TMVCF</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CLDN6, claudin-6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CLDN7, claudin-7</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CLDN8, claudin-8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CRACM1, Orai1, calcium release activated Ca2+ channel modulator 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CRACM2, calcium release activated Ca2+ channel modulator 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - CRACM3, calcium release activated Ca2+ channel modulator 3,</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - DCAL-2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Delta</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Delta-like 1, Dlk-1, DLK1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Desmoglein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - EMP2, EMP-2, epithelial membrane protein 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Ephrin A1, EFNA1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Ephrin A2, EFNA2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Ephrin A3, EFNA3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Ephrin A4, EFNA4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Ephrin A5, EFNA5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Ephrin B1, EFNB1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Ephrin B2, EFNB2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Ephrin B3, EFNB3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - ESDN, endothelial and smooth muscle cell-derived neuropilin-like molecule </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - FXYD5, dysadherin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Ferroportin, IREG-1, MTP-1, SLC40A1, iron regulated transported protein 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - FOLR1, FOLR-1, folate receptor 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - FOLR2, FOLR-2, folate receptor 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - FOLR3, FOLR-3, folate receptor 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - gpr34</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - gpr87, FKSG78, GPR95, G-protein-coupled receptor 95, G-protein-coupled receptor 87, KPG002, MGC131898 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - GCTM-5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - HEA, human epithelial antigen</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - HICSP, heat-inducible cell surface protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - HJV, hemojuvelin, HFE2, RGMc</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Jagged 2, HJ2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - LRP-1, LRP1, LDL receptor-related protein 1, </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - LRP-1b, LRP1b, LDL receptor-related protein 1b, </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - LRP-2, LRP2, LDL receptor-related protein 2, </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - LRP-4, LRP4, LDL receptor-related protein 4, </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - LRP-4, LRP4, LDL receptor-related protein 4, </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - LRP-5, LRP5, LDL receptor-related protein 5, </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - LRP-6, LRP6, LDL receptor-related protein 6, </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - LRP-8, LRP8, LDL receptor-related protein 8, </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - LOX-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Ly6D, E48</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - MARCO, macrophage receptor with collagenous structure</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - MCEMP, mast cell-expressed membrane protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - MFAP4, microfibrillar-associated protein 4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Notch, Lin-12, Tan 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Occludin, OCLN</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - OPRM1, OPRM-1, MOR-1, mu (type) opioid receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - PAR1, PAR-1, protease-activated receptor 1, protease/proteinase-activated receptor 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - PAR2, PAR-2, protease-activated receptor 2, C140, protease/proteinase-activated receptor 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - P-cadherin, CDH3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Piezo1, piezo-1, FAM38A, KIAA0233</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Piezo2, piezo-2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - RE2-L, RE2-like, GPR101</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - SAS1R, sperm acrosomal SLLP1 receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - scavenger receptor B1, SC-BI, SC-B1, CLA-1, SR-B1 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - SEL-OB, SVEP1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Serrate</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - SLITRK1, SLIT and NTRK-like protein 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - SLITRK2, SLIT and NTRK-like protein 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - SLITRK3, SLIT and NTRK-like protein 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - SLITRK4, SLIT and NTRK-like protein 4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - SLITRK5, SLIT and NTRK-like protein 5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - SLITRK6, SLIT and NTRK-like protein 6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - SRCL-P1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Stro-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - T-cadherin, H-cadherin, truncate cadherin, cadherin 13</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - TEM8, tumor endothelial marker 8, ANTXR1, anthrax toxin receptor 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Tetraspanin 10, TSPAN-10, TSN-10, TSN10, OCSP, oculospanin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Tight junction protein 1, TJP1, TJP-1, ZO1, ZO-1, zonula occludin 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Tight junction protein 2, TJP2, TJP-2, ZO2, ZO-2, zonula occludin 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - Tight junction protein 3, TJP3, TJP-3, ZO3, ZO-3, zonula occludin 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - TLR12, Toll-like receptor 12</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - TMEFF1, tomoregulin-1, tomoregulin 1, TR1, TR-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - TMEFF2, tomoregulin-2, tomoregulin 2, TPEF, TENB2, HPP1, CT120.2, TMEFF-2, TR2, TR-2, transmembrane protein with EGF-like and two follistatin-like domains 2, hyperplastic polyposis protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - TMEM216</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - TRPV6, transient receptor potential cation channel subfamily V member 6, TrpV6, CaT-like, CaT-L, calcium transport protein 1, CaT1, epithelial calcium channel 2, ECaC2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/28</class-ref> - VLDLR, very low density lipoprotein receptor</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD7, gp40</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD19, B4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD22, BL-CAM, Lyb8 (mouse), Lyb-8 (mouse), siglec-2, sialic acid-binding Ig-related lectin 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD31, endocam, myelomonocytic differentiation antigen, PECAM-1, platelet endothelial cell adhesion molecule 1, (platelet) gpIIa</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD33, gp67, siglec-3, sialic acid-binding Ig-related lectin 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD47, gp42, GR63, IAP, OA3, 1D8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD48, BCM1, blast-1, HuLy-M3, OX-45 (rat)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD56, Leu19, Leu-19, L1CAM, L1-CAM, neural cell adhesion factor L1, NCAM, neural cell adhesion molecule, NKH1, NKH-1, Ng-CAM, 8D9</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD66</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD66a, BGP, biliary glycoprotein, CEACAM1, CEACAM-1, carcinoembryonic antigen-related cell adhesion molecule 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD66b, CD67, CGM6, NCA-95, p100, CEACAM8, CEACAM-8, carcinoembryonic antigen-related cell adhesion molecule 8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD66c, NCA, NCA-50/90, CAECAM6, CEACAM-6, carcinoembryonic antigen-related cell adhesion molecule 6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD66d, CGM1, CEACAM3, CEACAM-3, carcinoembryonic antigen-related cell adhesion molecule 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD66f, PSG, pregnancy specific protein, SP-1, PSG1, PSG-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD79, B cell (antigen) receptor, BCR</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD79a, Igalpha, Ig alpha, MB1, mb-1, Iga</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD79b, Igbeta, Ig beta, MB2, mb-2, B29, Igb</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD83, HB15</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD85, LIR, GH1/75, VMP-55, LILR, leukocyte immunoglobulin-like receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD85a, LIR3, LIR-3, LIR-PBM17, ILT5, LILRB3, Ig-like transcript 5, ILT-5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD85b, ILT8, ILT-8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD85c, LIR-8, LIR-PBMNEW</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD85d, LIR2, LIR-2, MIR10, ILT4, LIR-PBM8, LILRB2, ILT-4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD85e, LIR4, LIR-4, LIR-PBM25, HM43, ILT6, ILT-6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD85f, ILT11, ILT-11</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD85g, ILT7, ILT-7</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD85h, LIR-7, LIR-7, LIR-PBMHH, ILT-1, ILT1, Ig-like transcript 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD85i, LIR6, LIR-6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD85j, LIR-1, LIR-18A3, LIR-P3G2, ILT-2, ILT2, Ig-like transcript 2, MIR7, LILRB1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD85k, LIR-5, LIR-PBM2, HM18, LILRB5, ILT3, ILT-3, Ig-like transcript 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD85l, ILT9, ILT-9, Ig-like transcript 9</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD85m, ILT10, ILT-10, Ig-like transcript 10</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD90, Thy1, Thy-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD96, TACTILE</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD100, semaphorin 4D, SEMA4D</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD101, BCP#4, GR14, V7</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD111, nectin 1, PRR1, PRR-1, poliovirus(-related) receptor 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD112, PRR2, PPR-2, poliovirus(-related) receptor 2, PVRL2, PVRL-2, poliovirus receptor-like 2, HVEB, herpesvirus entry protein B, herpesvirus entry mediator B, nectin 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD113, CDw113, nectin 3, PRR3, PRR-3, poliovirus(-related) receptor 3, PPR3, PVRR3, PVRL3, PVRL-3, poliovirus receptor-like 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD117, c-kit, SCFR, SCF-R, SCF receptor, stem cell factor receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD147, basigin, neurothelin, M6, emmprin, extracellular matrix metalloproteinase, TCSF, tumor collagenase stimulating factor, basoglin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD150, CDw150, IPO-3, SLAM, surface lymphocyte activation molecule</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD158</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD158a, p58.1, p58.1 KIR, EB6, KIR2DL1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD158b1, p58.2, p58.2 KIR, GL183, KIR2DL2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD158b2, p58.3, p58.3 KIR, KIR2DL3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD158c, KIRX, KIR X, KIR2DS6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD158d, KIR2DL4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD158e1, KIR3DL1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD158e2, KIR3DS1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD158f, KIR2DL5 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD158g, KIR2DS5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD158h, p50.1, KIR2DS1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD158i, p50.3, KIR2DS4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD158j, p50.2, KIR2DS2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD158k, p140, KIR3DL2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD159, CDw159, NKB1, NKB-1, p70, NKG2A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD160, CDw160, p140, NK1, NK28, BY55</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD166, ALCAM, activated leukocyte cell adhesion molecule, BEN (chicken), DM-GRASP (chicken), KG-CAM, neurolin (zebrafish), SC-1 (chicken)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD169, Siglec-1, sialic acid-binding Ig-related lectin 1, sialoadhesin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD170, Siglec-5, CD33-like 2, sialic acid-binding Ig-related lectin 5, OB-BP2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD171, L1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD172, SIRPs, signal regulatory proteins</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD172b, SIRPB1, SIRP beta-1, signal-regulatory protein beta 1, SIRP-B1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD172g, SIRPB2, SIRP beta-2, signal-regulatory protein beta 2, SIRP gamma, SIRP-B2 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD179</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD179a, IG1, immunoglobulin iota chain (or polypeptide), Vpre-B, VPREB1, VPREB-1, pre-B lymphocyte gene 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD179b, IGL5, immunoglobulin omega chain (or polypeptide), IGLL1, IGLL-1, immunoglobulin lambda-like polypeptide, 14.1, lambda 5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD200, MRC OX2, OX2 (rat), OX-2 (rat)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD223, LAG-3, lymphocyte activation gene 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD226, DNAM1, DNAM-1, DNAX accesory molecule 1, PTA1, PTA-1, platelet and T cell activation antigen 1, TLISA, T lineage-specific activation antigen 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD229, Ly9, Ly-9</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD244, 2B4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD244, 2B4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD300, CLM</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD300a, CD300LA, CD300 (molecule)-like family member A, CMRF35H, CMRF-35H, CMRF35H9, CMRF-35-H9, IRC1, IRC2, Irp60, IgSF12, CLM8, CLM-8, CMRF35-like molecule 8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD300b, CD300LB, CD300 (molecule)-like family member B, IREM3, IREM-3, immune receptor expressed by myeloid cells 3, CLM7, CLM-7, CMRF35-like molecule 7, TREM5, TREM-5, triggering receptor expressed on myeloid cells 5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD300c, CD300LC, CD300 (molecule)-like family member C, CLM6, CLM-6, CMRF35-like molecule 6, CMRF35A, CMRF-35A, LIR, IgSF16, immunoglobulin superfamily member 16, CMRF-35A1,CMRF35, CMRF-35</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD300e, CD300LE, CD300 (molecule)-like family member E, IREM2, IREM-2, immune receptor expressed by myeloid cells, CLM2, CLM-2, CMRF35-like molecule 2, PIgR2, poly-Ig receptor 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD300f, CD300LF, CD300 (molecule)-like family member F, IREM1, IREM-1, immune receptor expressed by myeloid cells 1, CLM1, CLM-1, CMRF35-like molecule 1, IgSF13, immunoglobulin superfamily member 13, MAIR-5, MAIR-V, myeloid-associated immunoglobulin-like receptor 5, leukocyte mono-Ig-like receptor 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD300g, CD300LG, CD300 (molecule)-like family member G, CLM9, CLM-9, CMRF35-like molecule 9, TREM4, TREM-4, triggering receptor expressed on myeloid cells 4, NEPMUCIN</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD305, LAIR1, LAIR-1, leukocyte-associated Ig-like receptor 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD306, LAIR2, LAIR-2, leukocyte-associated Ig-like receptor 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD315, CD9 partner 1, CD9P1, PTGFRN, prostaglandin F2 receptor negative regulator, FPRP, EWI-F, SMAP-6, FLJ11001, KIAA1436</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD316, EWI2, IgSF8, immunoglobulin superfamily member 8, PGRL, CD81P3, CD81 partner 3, KASP</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD319, SLAMF7, CRACC, SLAM family member 7, 19A, CS1, 19A24, CD2-like receptor activating cytotoxic cells, CD2 subset 1, LY9-like protein, FOAP-12, Ly9 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD321, JAM1, JAM-1, F11R, F11 receptor, KAT, JCAM, PAM-1, platelet adhesion molecule 1, junctional adhesion molecule 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD322, JAM2, JAM-2, VEJAM, PRO245, VE-JAM, vascular endothelial junction-associated molecule, junctional adhesion molecule 2 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD323, JAM3, JAM-3, junctional adhesion molecule 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD335, NKp46, NCR1, NCR-1, natural cytotoxicity triggering receptor 1, LY94, NK-p46, Ly-94 homolog</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD336, NKp44, NCR2, NCR-2, natural cytotoxicity triggering receptor 2, LY95, NK-p44, Ly-95 homolog</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD337, NKp30, NCR3, NCR-3, natural cytotoxicity triggering receptor 3, LY117, 1C7, NL-p30</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD352, SLAMF6, NTB-A, KAL.1, Ly108</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD353, SLAMF8, BLAME</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD354, TREM1, TREM-1, triggering receptor expressed in myeloid cells 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - A33, GPA33</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - A33-like 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - A34</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - AMIGO-2, amphoterin-induced protein 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - BTF, butyrophilin, BTN</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - BTN1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - BTN2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - BTN2A1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - BTN2A2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - BTN2A3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CADM-2, cell adhesion molecule 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CADM-3, cell adhesion molecule 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CADM-4, cell adhesion molecule 4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CAR, Coxsackie adenovirus receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - C-CAM</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD200R, CD200 receptor, OX-2R</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD200Ra, OX-2Ra</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CD200Rb, OX-2Rb</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CDO, cam-related gene down regulated by oncogenes</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CHL1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - contactin, neuro-1 antigen</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CTXL, cortical thymocyte receptor-like protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - CXADR, Coxsackie and adenovirus receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - DCC, deleted in colorectal carcinoma</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - EndoCAM, gp130</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - gp49B1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - gpVI, glycoprotein VI, TANGO 268</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - HCTX</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - human LIG-1 homolog (HLIG-1)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - IgSF4, immunoglobulin superfamily member 4, LDCAM, TSLC1, nectin-like 2, SynCAM, CADM-1, cell adhesion molecule 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - IgSF9, immunoglobulin superfamily member 9</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - JAM, juctional adhesion molecule</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - JAM-A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - JAM-B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - JAM-C</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - JAML, JAM-L, JAM-like</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - KIM-1, kidney injury molecule 1, TIM-1, HAVCR-1, hepatitis A virus cellular receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - KIRHy, killer cell Ig-like receptor-like protein(s)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - KIRREL, gp202, nephrin-like protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - LINGO-1, LRRN6, LRRN6A, FLJ14594, LERN1, MGC17422, UNQ201, Sp35</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - LIR-6A, LIR-PBM36-4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - LIR-6B, LIR-PBM36-2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - LILRB, PirB</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - Lisch-like</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - MadCAM-1, mucosal vascular addressin, mucosal addressin cell adhesion molecule</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - OMgp, oligodendrocyte myelin glycoprotein, MOgp, myelin oligodendrocyte glycoprotein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - OB-CAM, opioid binding cell adhesion molecule</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - Oscar, osteoclast-associated receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - PILRalpha, PILR alpha, FDF03</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - PILRbeta, PILR beta</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - RAGE, receptor for advanced glycated endproducts</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - ROBO1, roundabout homolog 1, Slit2 receptor, DUTT1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - ROBO2, roundabout homolog 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - ROBO3, roundabout homolog 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - ROBO4, roundabout homolog 4, axon guidance receptor (homolog) 4, ECSM4, magic roundabout, magic robo, MRB</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - ROR-1, ROR1, receptor tyrosine kinase orphan receptor 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - ROR-2, ROR2, receptor tyrosine kinase orphan receptor 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - siglec, sialic acid-binding Ig-related lectin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - siglec-4, sialic acid-binding Ig-related lectin 4, MAG, myelin-associated glycoprotein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - siglec -4b, sialic acid-binding Ig-related lectin 4b, SMP, Schwann cell myelin protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - siglec-6, sialic acid-binding Ig-related lectin 6, OB-BP1, CD33L</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - siglec-7, sialic acid-binding Ig-related lectin 7</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - siglec-8, sialic acid-binding Ig-related lectin 8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - siglec-9, sialic acid-binding Ig-related lectin 9</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - siglec-10, sialic acid-binding Ig-related lectin 10</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - siglec-11, sialic acid-binding Ig-related lectin 11</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - siglec-12, sialic acid-binding Ig-related lectin 12</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - siglec-13, sialic acid-binding Ig-related lectin 13</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - siglec-14, sialic acid-binding Ig-related lectin 14</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - siglec-15, sialic acid-binding Ig-related lectin 15</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - SPEX, spleen expressed protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - TARM, T cell interacting receptor on myeloid cells</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - TIM-3, T cell immunoglobulin and mucin domain 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - TOSO, PIGRL</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - TREM1, TREM-1, triggering receptor expressed in myleoid cells 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - TREM2, TREM-2, triggering receptor expressed in myeloid cells 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - TREM3, TREM-3, triggering receptor expressed in myeloid cells 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - TREM4, TREM-4, triggering receptor expressed in myeloid cells 4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - TREM11, TREM-11, triggering receptor expressed in myeloid cells 11</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - TREML1, TREML-1, TLT1, TLT-1, TREM like 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - TREML2, TREML-2, TLT2, TLT-2, TREM like 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - TREML3, TREML-3, TLT3, TLT-3, TREM like 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - TREML4, TREML-4, TLT4, TLT-4, TREM like 4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - UncB5, Unc-5 homolog B, netrin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2803</class-ref> - vaccinia virus B15 receptor</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2806</class-ref> - CD2, E-rosette receptor, LFA-2, lymphocyte function antigen 2, SRBC receptor, sheep red blood cell receptor, T11</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2806</class-ref> - CD2R, T11-3 </paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2809</class-ref> - CD3, TcR, CD3-TcR complex, TcR-CD3 complex, Ti, T3, Leu4, Leu-4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2809</class-ref> - CD247, zeta chain, CD3 zeta chain</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2812</class-ref> - CD4, T4, Leu3, Leu-3, L3T4 (mouse), W3/25 (rat)</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2815</class-ref> - CD8, T8, Leu2, Leu-2, Lyt-2 (mouse), Lyt2/3 (mouse)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2815</class-ref> - CD8a</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2815</class-ref> - CD8b</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2818</class-ref> - CD28, T44, Tp44</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2818</class-ref> - CD152, CTLA4, CTLA-4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2818</class-ref> - CD272, BTLA, B and T lymphocyte attenuator, B and T lymphocyte associated</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2818</class-ref> - CD278, ICOS, inducible costimulator, AILIM, inducible T cell co-stimulator, MGC39850, CRP-1, CD28-related protein 1, CLP, CTLA-4-like protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2818</class-ref> - CD279, PD-1, programmed death 1, PDCD1, programmed (cell) death 1, SLEB2, hPD-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2818</class-ref> - Tim-3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2818</class-ref> - zB7R1</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2821</class-ref> - ICAM molecules</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2821</class-ref> - CD50, CDw50, ICAM-3, ICAM-R, intercellular adhesion molecule 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2821</class-ref> - CD54, ICAM-1, intercellular adhesion molecule 1, rhinovirus receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2821</class-ref> - CD102, ICAM-2, intercellular adhesion molecule 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2821</class-ref> - CD242, ICAM-4, intercellular adhesion molecule 4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2821</class-ref> - ICAM-5, telencephalin</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2824</class-ref> - CD58, LFA-3, lymphocyte function antigen 3</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - B7 molecules</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - CD80, B7-1, B7, BB1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - CD86, B7-2, B70, BU63, FUN-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - CD273, B7-DC, PD-L2, B7DC, PDL2, Btdc, PDCD1LG2, PDCD1L2, programmed cell death 1 ligand 2, bA574F11.2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - CD274, B7-H1, B7H1, PD-L1, PDL1, PDCD1LG1, PDCD1L1, programmed cell death 1 ligand 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - CD275, B7-H2, B7H2, B7h, B7RP-1, GL50, LICOS, ligand of inducible costimulator, ICOS-L, ICOSL, ICOS ligand, KIAA0653, inducible T cell co-stimulator ligand, B7RP1, B7-related protein 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - CD276, B7-H3, B7H3, 2Ig-B7-H3, B7RP2, B7RP-2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - CD277, BTF5, BT3.1, BTN3A1, btyrophilin SF3 A1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - BTN3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - BT3.2, BTF4, BTN3A2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - BT3.3, BTF3, BTN3A3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - DC-HIL</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - 4Ig-B7-H3, 4Ig-B7H3 (also in <class-ref scheme="cpc">C07K16/30</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - B7-L1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - B7-H4, B7H4, B7x, B7S1, B7-S1Ov064, ovr110, VTCN1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - B7-H5, B7H5, VISTA</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - B7-H6, B7H6, NR3L1, NCR3LG1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - HHLA2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - BTF4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2827</class-ref> - pNKp30</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/283</class-ref> - CD16, Fc gamma receptor III, FcgammaRIII, low affinity receptor for monomeric IgG, low affinity Fcgamma receptor, Leu11, Leu-11</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/283</class-ref> - CD16a, FcgammaRIIIA, Fcgamma RIIIA, Fc gamma receptor IIIA</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/283</class-ref> - CD16b, FcgammaRIIIB, Fcgamma RIIIB, Fc gamma receptor IIIB</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/283</class-ref> - CD32, Fc gamma receptor II, FcgammaRII, low affinity receptor for aggregated IgG, Fcgamma RII</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/283</class-ref> - CD32A, Fcgamma receptor IIA, FcgammaRIIa, Fcgamma RIIA</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/283</class-ref> - CD32B, Fc gamma receptor IIB, FcgammaRIIb, Fcgamma RIIB</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/283</class-ref> - CD32C, Fc gamma receptor IIC, FcgammaRIIc, Fcgamma RIIC</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/283</class-ref> - CD64, Fc gamma receptor I, FcgammaRI, high affinity receptor for IgG, high affinity Fcgamma receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/283</class-ref> - CD89, FcalphaR, IgA receptor, receptor for IgA</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/283</class-ref> - CD307, IRTA2, immunoglobulin superfamily receptor translocation associated 2, BXMAS1, FLJ00333, RP11-217A12.1, FcRH5, FcRH-5, IRTA-2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/283</class-ref> - FcepsilonRI, Fc epsilon receptor I, FCEH receptor, high affinity receptor for IgE</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/283</class-ref> - IRTA1, IRTA-1, immune receptor translocation-associated 1, Fc receptor homolog 1, FcRH-4, immunoglobulin superfamily receptor translocation associated 1, FcRH4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/283</class-ref> - IRTA3, IRTA-3, immune receptor translocation-associated 3, Fc receptor homolog 3, FcRH-3, immunoglobulin superfamily receptor translocation associated 3, FcRH3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/283</class-ref> - IRTA4, IRTA-4, immune receptor translocation-associated 4, Fc receptor homolog 4, FcRH-2, immunoglobulin superfamily receptor translocation associated 4, FcRH2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/283</class-ref> - IRTA5, IRTA-5, immune receptor translocation-associated 5, Fc receptor homolog 5, FcRH-1, immunoglobulin superfamily receptor translocation associated 5, FcRH1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/283</class-ref> - IRTA6, IRTA-6, immune receptor translocation-associated 6, Fc receptor homolog 6, FcRH-6, immunoglobulin superfamily receptor translocation associated 6, FcRH6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/283</class-ref> - pIgR, poly-Ig receptor</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2833</class-ref> - CD1, T6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2833</class-ref> - CD1a, R4, HTA1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2833</class-ref> - CD1b, R1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2833</class-ref> - CD1c, R7, M241</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2833</class-ref> - CD1d, R3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2833</class-ref> - CD1e, R2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2833</class-ref> - CD74, Ii, MHC class II invariant chain, MHC class II gamma chain</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2833</class-ref> - HFE</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2833</class-ref> - MHC, major histocompatibility complex, HLA (human), H-2 (mouse)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2833</class-ref> - MICA, MHC-I A chain-related protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2833</class-ref> - MICB, MHC-I B chain-related protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2833</class-ref> - MICC, MHC-I C chain-related protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2833</class-ref> - MICD, MHC-I D chain-related protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2833</class-ref>- MICE, MHC-I E chain-related protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2833</class-ref> - MPYS (in mice), MPHS (in man), MHC II associated protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2833</class-ref> - b2m, beta-2 microglobulin, thymotaxin</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2836</class-ref> - CD106, VCAM-1, INCAM-110</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2839</class-ref> - CD103, alphaM290, HML1, HML-1, human mucosal lymphocyte 1 antigen, integrin alphaE</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2839</class-ref> - CD104, beta4 integrin, reg receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2839</class-ref> - LPAM-1, lymphocyte Peyer&apos;s patch adhesion molecule 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2839</class-ref> - pactolus</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2842</class-ref> - integrin beta1 (subunit-)containing molecule(s)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2842</class-ref> - CD29</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2842</class-ref> - CD49</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2842</class-ref> - CD49a, CD49a/CD29, VLA-1, very late antigen 1, integrin alpha1beta1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2842</class-ref> - CD49b, CD49b/CD29, VLA-2, very late antigen 2, ECMRII, ECMR-II, extracellular matrix receptor (type) II, (platelet) gpIa, (platelet) gpIa/IIa, integrin alpha2beta1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2842</class-ref> - CD49c, CD49c/CD29, VLA-3, very late antigen 3, ECMRI, ECMR-I, extracellular matrix receptor (type) I, integrin alpha3beta1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2842</class-ref> - CD49d, CD49d/CD29, VLA-4, very late antigen 4, integrin alpha4beta1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2842</class-ref> - CD49e, CD49e/CD29, VLA-5, very late antigen 5, ECMRVI, ECMR-VI, extracellular matrix receptor (type) VI, (platelet) gpIc, (platelet) gpIc/IIa, integrin alpha5beta1, fibronectin receptor alpha chain</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2842</class-ref> - CD49f, CD49f/CD29, VLA-6, very late antigen 6, integrin alpha6beta1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2842</class-ref> - LPAM-2, lymphocyte Peyer&apos;s patch adhesion molecule 2</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2845</class-ref> - integrin beta2 (subunit-)containing molecule(s)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2845</class-ref> - CD11</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2845</class-ref> - CD11a, CD11a/CD18, LFA-1, lymphocyte function antigen 1, LeuCAMa, integrin alphaL</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2845</class-ref> - CD11b, CD11b/CD18, CR3, C3biR, Mac-1, integrin alphaM</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2845</class-ref> - CD11c, CD11c/CD18, CR4, p150-95, integrin alphaX</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2845</class-ref> - CD18</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2848</class-ref> - integrin beta3 (subunit-)containing molecule(s)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2848</class-ref> - CD41, CD41/CD61, (platelet) gpIIb, (platelet) gpIIb/gpIIIa, (platelet) GpIIb/IIIa</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2848</class-ref> - CD51, CD51/CD61 VNR, VN-R, vitronectin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2848</class-ref> - CD61, CD41/CD61, CD51/CD61, (platelet) gpIIIa, (platelet) gpIIb/IIIa</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD23, FcepsilonRII, Fc epsilon receptor II, low affinity receptor for IgE, low affinity Fcepsilon receptor, Leu20, Leu-20, B6, BLAST 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD69, AIM, activation inducer molecule, EA1, EA-1, gp34/28, VEA (mouse), very early activation (mouse)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD72, Lyb-2 (mouse)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD94, kp43</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD159c, NKG2C, NKG2-C, KLRC2, killer cell lectin-like receptor subfamily C member 2, </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD161, NKRP1, NKR-P1A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD167a, DDR1, discoidin domain receptor 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD205, DEC-205, DEC205, LY75</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD206, (macrophage) mannose receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD207, langerin, CLEC4K</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD209, DC-SIGN, dendritic cell-specific ICAM-3 grabbing nonintegrin 1, DC-SIGN1, CLEC4L, CDSIGN</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD248, TEM1, tumor endothelial marker, endosialin, CD164L1, CD164 sialomucin-like 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD280, MRC2, MRC-2, mannose receptor C type 2, UPARAP, KIAA0709, ENDO180</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD299, DC-SIGNR, DC-SIGN related, CD209 antigen-like, probable mannose-binding C-type lectin, liver/lymph node-specific ICAM-3-grabbing nonintegrin 2, LSIGN, L-SIGN, DCSIGNR HP10347, DC-SIGN2, MGC47866, CD209L, C-type lectin domain family 4 member M, CLEC4M</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD301, CLEC10A, C-type lectin domain family 10 member A, C-type lectin superfamily member 14, HML2, CLECSF13, CLECSF14, MGL, HML</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD302, DCL-1, DCL1, BIMLEC, CLEC13A, KIAA0022, C-type lectin domain family 13 member A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD303, BDCA2, CLEC4C, C-type lectin domain family 4 member C, DLEC, HECL, CLECSF7, CLECSF11, PRO34150, blood dendritic cell antigen 2, dendritic cell lectin b</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD314, NKG2D, NKG2-D, KLR, KLRK1, killer cell lectin-like receptor subfamily K, D12S2489E, NK cell receptor D</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD327, CDw327, siglec6, diglec-6, sialic acid binding Ig-like lectin 6, CD33L, CD33 antigen-like 1, OBBP1, siglec-6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD328, CDw328, siglec7, diglec-7, sialic acid binding Ig-like lectin 7, p75, QA79, AIRM1, D-siglec precursor, adhesion inhibitory receptor molecule 1, siglec-7</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CD329, CDw329, siglec9, diglec-9, sialic acid binding Ig-like lectin 9, OBBP-like, OB binding protein, siglec-9</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - ASGR1, ASGR-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - ASGR2, ASGR-2, CLEC4H2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC1A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC1B, CLEC2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC2A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC2B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC2D</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC2L</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC3A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC3B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC3O</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC3Q</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC4A, DCIR, dendritic cell immunoreceptor, LLIR, CLECSF6, DDB27</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC4D, CLEC6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC4E, MINCLE</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC4F, KCLR</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC4G</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC5A, DVLR1, Dengue virus like receptor 1, MDL-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC6A, dectin-2, SDCMP, Schering dendritic cell membrane protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC7A, dectin-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC9A, DNGR1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC11A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC12A, MICL</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLEC14A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - CLL-1, CLL1, C-type lectin-like (family)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - COLEC10</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - conglutinin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - DCAL1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - DDR2, DDR-2, discoidin domain receptor 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - DX1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - FCER2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - Galectin 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - Galectin 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - Galectin 3, MAC2, macrophage galactose-specific lectin 2, CBP-35, epsilon BP, L-29, carbohydrate binding protein 35, human IgE binding factor epsilon</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - Galectin 4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - Galectin 5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - Galectin 6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - Galectin 7</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - Galectin 8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - Galectin 9</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - Galectin 10</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - Galectin 11</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - Galectin 12</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - Galectin 13</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - Galectin 14</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - Galectin 15</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - KLRB1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - LLT1, LLT-1, lectin-like transcript 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - MacropKLRF1hage antigen TMAH</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - MBL, mannose binding lectin, MBP, mannose binding protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - MRC1, MRC-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - MRC1L1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - OLR1, OLR-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2851</class-ref> - PLA2R1</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2854</class-ref> - selectins</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2854</class-ref> - CD62, selectin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2854</class-ref> - CD62E, E-selectin, ELAM-1, endothelial leukocyte adhesion molecule 1, LECAM-2, LEC-CAM-2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2854</class-ref> - CD62L, L-selectin, LAM-1, Leu8, Leu-8, LECAM-1, LEC-CAM-1, TQ1, TQ-1, MEL-14, DREG, peripheral lymph node homing receptor, pnHR, gp100MEL, gp110MEL</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2854</class-ref> - CD62P, P-selectin, LECAM-3, LEC-CAM-3, PADGEM, gmp140, GMP-140, platelet activation dependent granule external membrane</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2857</class-ref> - HIF, hypoxia-inducible factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2857</class-ref> - Nurr1, NR4A2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2857</class-ref> - PARR alpha, peroxisome proliferator activated receptor alpha</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2857</class-ref> - PARR delta/beta, peroxisome proliferator activated receptor delta/beta</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2857</class-ref> - PARR gamma, peroxisome proliferator activated receptor gamma</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2857</class-ref> - PXR</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2857</class-ref> - RORgammat, retinoic acid-related orphan receptor</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - Adrenoreceptors, adrenergic receptors, adrenoceptors, epinephrine receptors, adrenaline receptors, norepinephrine receptors, noradrenaline receptors (also in <class-ref scheme="cpc">C07K16/2869</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - Alpha-1 adrenoreceptor, alpha-1 adrenergic receptor, alpha-1 adrenoceptor, A1AR, alpha-1 AR, ADRA1R, ALPHA1AR (also in <class-ref scheme="cpc">C07K16/2869</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - Alpha-2 adrenoreceptor, alpha-2 adrenergic receptor, alpha-2 adrenoceptor, A2AR, alpha-2 AR, ADRA2R, ALPHA2AR (also in <class-ref scheme="cpc">C07K16/2869</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - Beta-1 adrenoreceptor, beta-1 adrenergic receptor, beta-1 adrenoceptor, B1AR, beta-1 AR, ADRB1R, BETA1AR, RHR (also in <class-ref scheme="cpc">C07K16/2869</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - Beta-2 adrenoreceptor, beta-2 adrenergic receptor, beta-2 adrenoceptor, B2AR, beta-2 AR, ADRB2R, BETA2AR (also in <class-ref scheme="cpc">C07K16/2869</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - Acetylcholine receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - Neuromediator receptors</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - BGT-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - Dopamine receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - GABA receptor subtype A, GABAAR, gamma aminobutyric acid receptor subtype A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - NK1, tachykinin NK1 receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - NK2, tachykinin NK2 receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - NK3, tachykinin NK3 receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - NMDAR, M-methyl-D-aspartate receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - NMUR1, neuromedin U receptor 1, FM-3, gpr66, G-protein coupled receptor 66</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - NMUR2, neuromedin U receptor 2, FM-4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - NR1 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - NR2 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - NR2A </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - NR2B </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - NR2C </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - NR2D </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - NR3 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - Serotonin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - SorLA, sorting protein-related receptor, LR11</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - SorCS1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - SorCS2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - SorCS3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/286</class-ref> - Sortilin, NTR3, NTR-3, neurotensin receptor 3, glycoprotein 95, gp95 </paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - growth factor receptors</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - CD135, FLT3, flt-3, flk-2 (mouse), STK-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - CD140, PDGFR</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - CD140a, PDGFRalpha, platelet derived growth factor receptor alpha</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - CD140b, PDGFRbeta, platelet derived growth factor receptor beta</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - CD202b, Tek, Tie2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - CD221, IGF1R, IGF1-R, insulin-like growth factor 1 receptor, insulin-like growth factor I receptor, IGFIR, IGFI-R </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - CD222, CIMPR, CI-MPR, M6PR, M6P-R, mannose-6 phosphate receptor, IGF2R, IGF2-R, insulin-like growth factor 2 receptor, IFGIIR, IGFII-R, insulin-like growth factor II receptor, MPRI</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - CD292, BMPR1A, bone morphogenetic protein receptor type IA, ALK3, ALK-3, ACVRLK3, activin A receptor type II-like kinase 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - CD293, CDw293, BMPR1B, bone morphogenetic protein receptor type IB, ALK6, ALK-6, serine/threonine receptor kinase</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - CD304, BDCA4, NRP1, NRP-1, npn-1, neuropilin 1, VEGF165R</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - CD309, KDR, kinase insert domain receptor, FLK1 (mouse), flk-1 (mouse), fetal liver kinase 1 (mouse), VEGFR2, VEGFR-2, VEGF receptor 2, vascular endothelial growth factor receptor 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - CD331, FGFR1, fibroblast growth factor receptor 1, heparin-binding FGF receptor, basic FGF receptor, FLG protein, CEK, FLT2, flt-2, KAL2, BFGFR, C-FGR, N-SAM</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref>- CD332, FGFR2, fibroblast growth factor receptor 2, keratinocyte growth factor receptor, BEK, JWS, CEK3, CFD1, ECT1, KGFR, TK14, TK25, BFR-1, K-SAM </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - CD333, FGFR3, fibroblast growth factor receptor 3, ACH, CEK2, TK4, HSFGFR3EX</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - CD334, FGFR4, fibroblast growth factor receptor 4, TKF, JTK2, MGC20292</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - Adrenomedullin receptor, CLR, RAMP2, RAMP3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - Activin receptor, ActR </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - Angiogenin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - Axl</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - Boc, bioregional Cdon-binding protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - Boi, brother of Ihog</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - EGFR, EGF-R, EGFR1, EGFR-1, EGF receptor, EGF receptor 1, epidermal growth factor receptor, epidermal growth factor receptor 1, urogastrone receptor, Her1, ErbB1, ErbB-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - EPOR, EPO-R, EPO receptor, erythropoietin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - ERRP, EGF receptor-related protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - FGFR5, fibroblast growth factor receptor 5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - Frizzled (receptors), FZD</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - FZD-1, FZD1, Frizzled 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - FZD-2, FZD2, Frizzled 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - FZD-3, FZD3, Frizzled 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - FZD-4, FZD4, Frizzled 4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - FZD-5, FZD5, Frizzled 5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - FZD-6, FZD6, Frizzled 6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - FZD-7, FZD7, Frizzled 7</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - FZD-8, FZD8, Frizzled 8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - FZD-9, FZD9, Frizzled 9</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - FZD-10, FZD10, Frizzled 10</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - GasI, growth arrest-specific 1 (protein) </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - GFR, glial cell line-derived neurotrophic factor family receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - GFRalpha1, GFRA1, GDNF receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - GFRalpha2, GFRA2, neurturin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - GFRalpha3, GFRA3, artemin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - GFRalpha4, GFRA4, persephin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - GRP73a</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - GRP73b </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - Heregulin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - HGFR, HGF-R, HGF receptor, c-met, hepatocyte growth factor receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - Hip, HhipI, hedgehog-interacting protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - Ihog, interference hedgehog</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - Mer</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - MSPR, MSP receptor, macrophage stimulating protein receptor, RON</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - Neuregulin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - Neuropilin 2, npn-2, nrp-2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - Nogo receptor 1, Nogo receptor, NogoR, NogoR-1, NgR, NgR-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - Osteogenin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - Patched, Ptch</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - PCDGFR, PCDGF receptor, gp88 receptor, PC cell derived growth factor receptor, Rse, Sky, rGP88, Tyro3, Etk2, Tif</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - RET</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - Smoothened, Smo</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - TGFR, TGF-R, TGF receptor, transforming growth factor receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - Tie1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - TrkA</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - TrkB</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - TrkC</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - VEGFR1, VEGFR-1, VEGF receptor 1, vascular endothelial growth factor receptor 1, FLT1 (mouse), flt-1 (mouse)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - VEGFR3, VEGFR-3, VEGF receptor 3, vascular endothelial growth factor receptor 3, FLT4, flt-4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - ZAQ, EG-VEGF receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2863</class-ref> - I1E </paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - chemokine en cytokine receptors</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD25, Tac, IL-2R, IL-2Ralpha, IL-2R alpha (chain), IL-2 receptor alpha (chain), interleukin-2 receptor alpha (chain), TCGFR, TCGF-R, TCGF receptor, T cell growth factor receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD110, MPL, TPOR, TPO-R, TPO receptor, thrombopoietin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD114, G-CSFR, G-CSF-R, G-CSF receptor, granulocyte colony-stimulating factor receptor, CSF3R, CSF-3R</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD115, M-CSFR, M-CSF-R, M-CSF receptor, macrophage colony-stimulating factor receptor, CSF1R, CSF-1R, c-fms</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD116, GM-CSFR, GM-CSF-R, GM-CSF receptor, granulocyte macrophage colony-simulating factor receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD118, LIFR, leukemia inhibitory factor receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD119, CDw119, IFNgR, IFN-gamma receptor, interferon gamma receptor, IFNGR</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD121a, IL-1R type 1, IL-1 receptor type 1, interleukin-1 receptor type 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD121b, IL-1R type 2, IL-1 receptor type 2, interleukin-1 receptor type 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD122, IL-2Rbeta, IL-2R beta (chain), IL-2 receptor beta (chain), interleukin-2 receptor beta (chain)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD123, IL-3Ralpha, IL-3R alpha (chain), IL-3 receptor alpha (chain), interleukin-3 receptor alpha (chain), CDw123 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD124, IL-4R, IL-4 receptor, interleukin-4 receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD125, CDw125, IL-5Ralpha, IL-5R alpha (chain), IL-5 receptor alpha (chain), interleukin-5 receptor alpha (chain)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD126, IL-6R, IL-6 receptor, interleukin-6 receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD127, IL-7R, IL-7 receptor, interleukin-7 receptor, IL-7Ralpha, IL-7R alpha (chain), IL-7 receptor alpha (chain), interleukin-7 receptor alpha (chain)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CDw128</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD129, IL-9R, IL-9 receptor, interleukin-9 receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD130, gp130</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD131, CDw131, common beta chain, common cytokine receptor beta chain</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD132, common gamma chain, common cytokine receptor gamma chain</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD181, CD128a, CDw128a, CXCR1, chemokine (type) CXC receptor 1, IL-8RA, IL-8Ralpha, IL-8 receptor A, interleukin-8 receptor A, interleukin-8 receptor alpha</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD182, CD128b, CDw128b, CXCR2, chemokine (type) CXC receptor 2, IL-8RB, IL-8Rbeta, IL-8 receptor B, interleukin-8 receptor B, interleukin-8 receptor beta</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD183, CXCR3, chemokine (type) CXC receptor 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD184, CXCR4, chemokine (type) CXC receptor 4, fusin, HUMSTR, LESTR</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD185, CXCR5, chemokine (type) CXC receptor 5, BLR1, BLR-1, Burkitt lymphoma receptor 1, MDR15</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD186, CDw186, CXCR6, chemokine (type) CXC receptor 6, BONZO, STRL33, TYMSTR</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD191, CCR1, chemokine (type) CC receptor 1, CKR-1, CC-CKR1, CMKBR1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD192, CCR2, chemokine (type) CC receptor 2, CKR-2, CC-CKR2, MPC-1-R, MCP-1R, MCP-1 receptor, CCR2A, CCR2B, CKR2A, CKR2B, CMKBR2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD193, CCR3, chemokine (type) CC receptor 3, CKR-3, CC-CKR3, CMKBR3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD194, CCR4, chemokine (type) CC receptor 4, CKR-4, CC-CKR4, CMKBR4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD195, CCR5, chemokine (type) CC receptor 5, CKR-5, CC-CKR5, CMKBR5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD196, CCR6, chemokine (type) CC receptor 6, CKR-6, CC-CKR6, CMKBR6, BN-1, DCR2, CKRL3, DRY-6, GPR29, GPRCY4, GPR-CY4, STRL22, CKR-L3, LARC receptor </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD197, CDw197, CCR7, chemokine (type) CC receptor 7, CKR-7, CC-CKR7, CMBKR7</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD197, CDw197, CCR7, chemokine (type) CC receptor 7, CKR-7, CC-CKR7, CMBKR7</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD198, CDw198, CCR8, chemokine (type) CC receptor 8, CKR-8, CC-CKR8, CMBKR8, CY6, TER1, CKRL1, CKR-L1, GPR-CY6, CMKBRL2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD199, CDw199, CCR9, chemokine (type) CC receptor 9, CKR-9, CC-CKR9, CMBKR9, GPR28, GPR-9-6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD210, CDw210, IL-10R, IL-10 receptor, interleukin-10 receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD212, IL-12Rbeta1, IL-12 receptor beta 1, interleukin-12 receptor beta 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD213a1, IL-13R alpha 1, interleukin-13 receptor alpha 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD213a2, IL-13R alpha 2, interleukin-13 receptor alpha 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD217, IL-17R, IL-17 receptor, interleukin-17 receptor, zcytor14</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD218a, CDw218A, IL-18RA, IL-18R alpha, interleukin-18 receptor 1, interleukin-18 receptor alpha, IL1RRP, IL-1Rrp </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - CD218b, CDw218B, IL-18RB, IL-18R beta, interleukin-18 receptor beta, interleukin-18 receptor accessory protein, ACPL, IL18RAP</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - chemerinR, chemerin receptor, dez, CMKLR1, CMKLR-1, chemokine-like receptor 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphA1, ephrin receptor A1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphA2, ephrin receptor A2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphA3a, ephrin receptor A3a</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphA3b, ephrin receptor A3b</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphA4, ephrin receptor A4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphA5a, ephrin receptor A5a</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphA5b, ephrin receptor A5b</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphA6, ephrin receptor A6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphA7, ephrin receptor A7</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphA8, ephrin receptor A8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphA9, ephrin receptor A9,</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphA10, ephrin receptor A10</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphB1, ephrin receptor B1, Elk, Cek6, Net, Hek6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphB2, ephrin receptor 2, Cek5, Nuk, Erk, Qek5, Tyro5, Sek3, Hek5, Drt</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphB2a, ephrin receptor B2a</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphB2b, ephrin receptor B2b</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphB3, ephrin receptor B3, Cek10, Hek2, Mdk5, Tyro6, Sek4, Hek4, Mek4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphB4, ephrin receptor B4, Htk, Myk1, Mdk2, Tyro11, hepatoma transmembrane kinase (also in <class-ref scheme="cpc">C07K16/30</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphB5, ephrin receptor B5, Cek9, Hek9</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - EphB6, ephrin receptor B6, Mep</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - Hek7, Cek7</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - Hek8, Cek8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - Hek11</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IFNAR, interferon alpha receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IFNAR-1, interferon alpha receptor 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IFNAR-2, interferon alpha receptor 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-1RAP, IL1RAP, IL-1RAcP, IL1R3, c3orf13, Il-1 receptor accessory protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-11R, IL-11 receptor, interleukin-11 receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-14R, IL-14 receptor, interleukin-14 receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-15R, IL-15 receptor, interleukin-15 receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-16R, IL-16 receptor, interleukin-16 receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-17FR, IL-17F receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-17R, IL-17 receptor, interleukin-17 receptor, IL-17RA, IL-17 receptor A, interleukin-17 receptor A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-17RB, IL-17 receptor B, interleukin-17 receptor B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-17RC, IL-17 receptor C, interleukin-17 receptor C</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-17RD, IL-17 receptor D, interleukin-17 receptor D</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-17RE, IL-17 receptor E, interleukin-17 receptor E</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-17RF, IL-17 receptor F, interleukin-17 receptor F</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-19R, IL-19 receptor, interleukin-19 receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-20R, IL-20 receptor, interleukin-20 receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-21R, IL-21 receptor, interleukin-20 receptor, MU-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-22RA, IL-22 receptor alpha, interleukin-22 receptor alpha, zcytor11</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-23R, IL-23 receptor, interleukin-23 receptor, DCRS5, DNAX cytokine receptor subunit 5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-27R, IL-27 receptor, interleukin-27 receptor, TCCR</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-27RA, WXS-1, IL-27 receptor alpha, interleukin 27 receptor alpha</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-28R, IL-28 receptor, interleukin-28 receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-31RA, IL-31 receptor A, NR10, cytokine receptor nr. 10, CRL, CRL3, GLM-R, GPL, MGC125346, PRO21384, cytokine receptor-like 3, WAP5, whey acidic protein 5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - IL-33R, IL-33 receptor, interleukin-33 receptor, ILRL1, ST2, T1/ST2, Fit-1, DER4, DER-4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - L-CCR, LPS-inducible CC chemokine receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - TPOR, TPO-R, TPO receptor, thrombopoietin receptor, Mp1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - WSX receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2866</class-ref> - zalpha11</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - hormone receptors</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - CD220, insulin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - CD295, LEPR, leptin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Adrenoreceptors, adrenergic receptors, adrenoceptors, epinephrine receptors, adrenaline receptors, norepinephrine receptors, noradrenaline receptors (also in <class-ref scheme="cpc">C07K16/286</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Alarin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Alpha-1 adrenoreceptor, alpha-1 adrenergic receptor, alpha-1 adrenoceptor, A1AR, alpha-1 AR, ADRA1R, ALPHA1AR (also in <class-ref scheme="cpc">C07K16/286</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Alpha-2 adrenoreceptor, alpha-2 adrenergic receptor, alpha-2 adrenoceptor, A2AR, alpha-2 AR, ADRA2R, ALPHA2AR (also in <class-ref scheme="cpc">C07K16/286</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Androgen receptor, AR</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Angiotensin-II type-1 receptor, AT1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Angiotensin-II type-2 receptor, AT2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Anti-M&#252;llerian hormone type II receptor, AMH type II receptor, AMH receptor type II, AMHIIR, AMHRII, MISIIR, MISRII, MIFIIR, MIFRII, AMHR-II, AMH-RII, MISR-II, MIS-RII, MIFR-II, MIF-RII</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Apelin receptor, AGTRIA, APJ</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Apelin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Atrial natriuretic factor complex</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Atriopeptin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Atrial natriuretic peptide receptor, ANP receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Beta-1 adrenoreceptor, beta-1 adrenergic receptor, beta-1 adrenoceptor, B1AR, beta-1 AR, ADRB1R, BETA1AR, RHR (also in <class-ref scheme="cpc">C07K16/286</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Beta-2 adrenoreceptor, beta-2 adrenergic receptor, beta-2 adrenoceptor, B2AR, beta-2 AR, ADRB2R, BETA2AR (also in <class-ref scheme="cpc">C07K16/286</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Bombesin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Calcitonin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Calcitonin gene-related peptide receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Cardionatrin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Cardiodilatin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Cholecystokinin receptor, CCK receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Chorionic gonadotropin receptor, HCG receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Chorionic somatomammotropin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Corticotropin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Corticotropin releasing factor receptor, CRF receptor, urotensin receptor </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - CRF1R, corticotropin-releasing factor 1 receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - CRF2R, corticotropin-releasing factor 2 receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Endorphin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Endothelin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Enkephalin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Follicle-stimulating hormone receptor, FSH receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Galanin receptor, GAL receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Galanin-like peptide receptor, GALP receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Gastrin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Gastrin releasing peptide receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Ghrelin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - GIP receptor, gastric inhibitory polypeptide receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Glucagon receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - GLP-1 receptor, glucagon-like peptide 1 receptor, GLP1R, GLP-1R</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - GLP-2 receptor, glucagon-like peptide 2 receptor, GLP2R, GLP-2R</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Growth hormone receptor, GH receptor, somatotropin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Growth hormone releasing factor receptor, GHRF receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Lipotropin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Luteinising hormone receptor, LH receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Melanocortin 1 receptor, MC1R, MCR1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Melanocortin 2 receptor, MC2R, MCR2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Melanocortin 3 receptor, MC3R, MCR3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Melanocortin 4 receptor, MC4R, MCR4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Melanocortin 5 receptor, MC5R, MCR5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Melanocyte stimulating hormone receptor, MSH receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Melanotropin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Motilin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Orphan glycoprotein hormone receptor, OGH receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Parathyroid hormone receptor, parathormone receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Parathyroid hormone related peptide receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Prolactin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Prostaglandin receptors</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Prostaglandin E2 receptor, PGE2 receptor, PGE2R</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Relaxin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Salusin alpha receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Salusin beta receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Secretin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Serotonin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Somatostatin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Substance P receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - TFF3 receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Thymopoietin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Thymosin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Thyroid stimulating hormone receptor, TSH receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Vasoactive intestinal contractor receptor, VIC receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2869</class-ref> - Vasoactive intestinal peptide receptor 1, VIP receptor, FLJ41949, HVR1 II, PACAP-R-2, RCD1, RDC1, VAPC1, VIP-R1, VIPR, VIRG, VPAC1, VPCAP1R</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2872</class-ref> - CD230, prion protein, PrP, PrPsc</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2875</class-ref> - NGF/TNF (ligand) superfamily</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2875</class-ref> - CD70, CD27L, CD27-L, CD27 ligand, Ki-24, TNFSF7, tumor necrosis factor (ligand) superfamily member 7</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2875</class-ref> - CD153, CD30L, CD30-L, CD30 ligand, TNFSF8, tumor necrosis factor superfamily member 8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2875</class-ref> - CD154, CD40L, CD40-L, CD40 ligand, CD40CR, gp39, T-BAM, 5c8, TRAP, TNFSF5, tumor necrosis factor (ligand) superfamily member 5, IMD3, HIGM1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2875</class-ref> - CD178, CD95L, CD95-L, CD95 ligand, FasL, Fas-L, Fas ligand, Apo-1L, Apo-1 ligand, APT1LG1, TNFSF6, tumor necrosis factor (ligand) superfamily member 6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2875</class-ref> - CD252, CD134L, CD134-L, CD134 ligand, gp34, OX40L, OX40-L, OX40 ligand, Act-4L, Act-4-L, Act-4 ligand, TXGP1, TNFSF4, TNFSF-4, tumor necrosis factor (ligand) superfamily member 4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2875</class-ref> - CD253, AIM-I, apoptosis-inducing molecule I, AGP-1, Apo-2L, Apo-2 ligand, TL2, TRAIL, TNFSF10, TNFSF-10, tumor necrosis factor (ligand) superfamily member 10, TL-2 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2875</class-ref> - CD254, RANKL, RANK-L, RANK ligand, OPGL, OPG-L, OPG ligand, osteoprotegerin ligand, osteoprotegerin binding protein, ODF, sODF, osteoclast differentiation factor, TRANCE, hRANKL2, TNFSF11, TNFSF-11, tumor necrosis factor (ligand) superfamily member 11, receptor activator of NF-kappaB ligand, receptor activator of NF-kB ligand</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2875</class-ref> - CD255, Apo-3L, Apo-3 ligand, TRELL, TRAIL-related ligand, TREPA, TNF-related endothelial proliferative agent, TWEAK, T cell ligand weakly inducing apoptosis, DR3L, TNFSF12, tumor necrosis factor (ligand) superfamily member 12</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2875</class-ref> - CD256, APRIL, a proliferation-inducing ligand, TNF-related death ligand, TRDL, TRDL-1, TL3, TL-3, TNF ligand 3, TNF gamma, VEGI, vascular endothelial cell growth inhibitor, TALL2, TALL-2, TNFSF13, TNFSF-13, tumor necrosis factor (ligand) superfamily member 13</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2875</class-ref> - CD257, BAFF, B cell activation factor, BLyS, TALL1, TALL-1, THANK, ZTNF4, TNFSF20, delta BAFF, TNFSF13B, TNFSF-13B, tumor necrosis factor (ligand) superfamily member 13B, ntn-2, kay-ligand, neutrokine</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2875</class-ref> - CD258, LTg, HVEML, LIGHT, TNFSF14, TNFSF-14, tumor necrosis factor (ligand) superfamily member 14, TL5, TL-5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2875</class-ref> - AIM-II, apoptosis-inducing molecule II</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2875</class-ref> - EDA,EDA1, ectodysplasin (isoform) A1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2875</class-ref> - EDA2, ectodysplasin (isoform) A2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2875</class-ref> - TL1A, TL-1A, TNFSF15, tumor necrosis factor superfamily member 15</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2875</class-ref> - ZTNF13</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - NGFR/TNFR superfamily, NGF receptor/TNF receptor superfamily</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD27, TNFRSF7, tumor necrosis factor receptor superfamily member 7, Tp55, S152, T14</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD30, Ber-H2, Ki-1, D1S166E, TNFRSF8, tumor necrosis factor receptor superfamily member 8, </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD40, TNFRSF5, tumor necrosis factor receptor superfamily member 5, p50, Bp50</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD40-associated protein, CAP</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD95, Apo-1, Fas, APT1, TNFRSF6, tumor necrosis factor receptor superfamily member 6, apoptosis antigen 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD120, TNFR, TNF receptor, tumor necrosis factor receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD120a, 55 kD TNFR, TNFR-1, TNFR-I, TNF receptor 1, TNF receptor I, TNFAR, TNFR60, p55, TNFRSF1A, tumor necrosis factor receptor superfamily member 1A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD120b, 75 kD TNFR, TNFR-2, TNFR-II, TNF receptor 2, TNF receptor II, TNFBR, TNFR80, p75, TNFRSF1B, tumor necrosis factor receptor superfamily member 1B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD134, Act-4, OX40, OX-40, Stan-40, ACT35, TXGP1L, TNFRSF4, tumor necrosis factor receptor superfamily member 4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD137, CDw137, ILA, induced by lymphocyte activation, 4-1BB, TNFRSF9, tumor necrosis factor receptor superfamily member 9</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD260, LTbetaR, lymphotoxin beta receptor, LTbeta receptor, TNFRSF3, TNFRSF-3, tumor necrosis factor receptor superfamily member 3, TNFCR, TNF-R-III, TNFR2-RP</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD261, DR4, death receptor 4, death domain-containing receptor 4, TR1, TRAILR1,TRAIL-R1, TRAIL receptor 1, Apo-2, APO2, apoptosis antigen 2, TNFRSF10a, TNFRSF-10a, tumor necrosis factor receptor superfamily member 10a, MGC9365</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD262, DR5, death receptor 5, death domain-containing receptor 5, TR2 (?), TRAILR2, TRAIL-R2, TRAIL receptor 2, KILLER, TRICK2, TRICKB, ZTNFR9, TNFRSF10b, TNFRSF-10b, tumor necrosis factor receptor superfamily member 10b</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD263, TR5, TNFR-5, TNF receptor 5, TRAILR3, TRAIL-R3, TRAIL receptor 3, TRID, LIT, DCR1, TNFRSF10c, TNFRSF-10c, tumor necrosis factor receptor superfamily member 10c</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD264, TR4, TRAILR4, TRAIL-R4, TRAIL receptor 4, DCR2, TRUNDD, TNFRSF10d, TNFRSF-10d, tumor necrosis factor receptor superfamily member 10d</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD265, RANK, receptor activator of NF-kappaB, ODAR, osteoclast differentiation and activation receptor, TRANCER, TRANCE-R, TRANCE receptor, EOF, FEO, OFE, ODFR, PDB2, TNFRSF11a, TNFRSF-11a, tumor necrosis factor receptor superfamily member11a, osteoclast differentiation factor receptor, receptor activator of NF-kB</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD266, TWEAKR, TWEAK-R, TWEAK receptor, FN14, TNFRSF12a, TNFRSF-12a, tumor necrosis factor receptor superfamily member 12a, FGF-inducible 14</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD267, TACI, transmembrane activator and CAML interactor, TNFRSF13b, TNFRSF-13b, tumor necrosis factor receptor superfamily member 13b</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD268, BAFFR, BAFF-R, BAFF receptor, TNFRSF13c, TNFRSF-13c, tumor necrosis factor receptor superfamily member 13c, TR13c</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD269, BCMA, B cell maturation antigen, TNFRSF17, TNFRSF-17,tumor necrosis factor receptor superfamily 17, TNFRSF13B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD271, NGFR, NGF-R, NGF receptor, nerve growth factor receptor, p75(NTR), TNFRSF16, TNFRSF-16, tumor necrosis factor receptor superfamily member 16</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD357, AITR, GITR, TNFRSF18, tumor necrosis factor receptor superfamily member 18</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - CD358, DR6, death (domain(-containing)) receptor 6, TR7, TRAIL-R7, TRAIL receptor 7, TNFRSF21, tumor necrosis factor receptor superfamily member 21</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - BR3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - DcR3, TNFRSF6B, tumor necrosis factor receptor superfamily member 6B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - DR3, death receptor 3, death domain-containing receptor 3, TR3, TRAIL-R3, TRAIL receptor 3, DDR3, TRAMP, WSL-1, LARD, Apo-3, APO3, apoptosis antigen 3, TNFRSF12, tumor necrosis factor receptor superfamily member 12, TNFRSF25</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - EDAR, TNFRSF27, EDA1 receptor, ectodysplasin A1 receptor, EDA1R</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - EDA2R, ectodysplasin A2 receptor, TNFRSF27, tumor necrosis factor receptor superfamily member 27, </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - XEDAR (?), X-linked EDA1 receptor, X-linked EDAR</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - FLINT, OPG-3, osteoprotegerin 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - HVEM, herpes simplex virus entry mediator, TR2, ATAR, LIGHTR, LIGHT-R, LIGHT receptor, HveA, TNFRSF14, tumor necrosis factor receptor superfamily member 14 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - OPG, osteoprotegerin, OCIF, osteoclastogenesis inhibitory factor, TNFRSF11b, tumor necrosis factor receptor superfamily member 11B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - TNF-BP-I, tumor necrosis factor binding protein I</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - TNF-BP-II, tumor necrosis factor binding protein II</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - TRADD, TNF receptor 1 associated death domain protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - TR6, TRAILR6, TRAIL-R6, TRAIL receptor 6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - TR13, TRAILR13, TRAIL-R13, TRAIL receptor 13</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - TR14, TRAILR14, TRAIL-R14, TRAIL receptor 14</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - TROY</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2878</class-ref> - XEDAR</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2881</class-ref> - CD71, TfR, transferrin receptor, T9</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2884</class-ref> - CD44, ECMRIII, ECMR-III, extracellular matrix receptor (type) III, gp85, Hermes, H-CAM, HUTCH-1, pgp-1, phagocytic glycoprotein 1, p85</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2884</class-ref> - CD44R, CD44v </paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2887</class-ref> - CD20, B1, Bp35</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/289</class-ref> - CD45, B220, LCA, leukocyte common antigen, T200</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/289</class-ref> - CD45R</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/289</class-ref> - CD45RA</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/289</class-ref> - CD45RB</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/289</class-ref> - CD45RC</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/289</class-ref> - CD45RO </paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2893</class-ref> - CD52, CDw52, CAMPATH-1</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD5, Leu1, Leu-1, Ly-1, Lyt-1 (mouse), T1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD6, T12</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD9, MRP-1, p24, MIC3, TSPAN29, TSPAN-29</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD10, CALLA, common acute lymphoblastic leukemia antigen, enkephalinase, gp100, NEP, neutral endopeptidase (also in <class-ref scheme="cpc">C07K16/40</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD12, CDw12, p90-120</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD13, APN, aminopeptidase N, gp150 (also in <class-ref scheme="cpc">C07K16/40</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD14, LPS receptor, Mo2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD15, Lewis X, Lex, Le-x, x-hapten, 3-FAL, lacto-N-fucopentaose III, SSEA-1, stage-specific embryonic antigen 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD15s, sialylated CD15, sialylated Lewis X, sialylated Lex, sialylated Le-x, SLex</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD15u, sulphated CD15, sulfated Lewis X, sulfated Lex</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD17, CDw17, lacCer, lactosyl ceramide, lactosylceramide</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD21, B2, CR2, C3d receptor, EBVR, EBV-R, EBV receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD24, HAS, heat-stable antigen, M1/69-J11d, BA-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD26, ADA binding protein, DPPIV, DPP IV, dipeptidyl peptidase IV (also in <class-ref scheme="cpc">C07K16/40</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD34, gp105-120</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD35, CR1, C3bR, C3b receptor, C4bR, C4b receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD36, gp88, OKM5, PASIV, (platelet) gpIIIb, (platelet) gpIV</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD37, gp52-40</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD38, T10</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD39</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD42</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD42a, (platelet) gpIX</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD42b, (platelet) gpIbalpha, (platelet) gpIb alpha, (platelet) gpIba</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD42c, (platelet) gpIbbeta, (platelet) gpIb beta, (platelet) gpIbb</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD42d, (platelet) gpV</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD43, gpL115, leukosialin, leukocyte sialoglycoprotein, LSCP, sialophorin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD46, MCP, membrane cofactor protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD47R, CDw149</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD53, OX-44 (rat)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD55, DAF, decay accelerating factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD57, Leu7, Leu-7, HNK1, HNK-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD59, HRF20, H19, MACIF, membrane attack complex inhibition factor, MIRL, membrane inhibitor of reactive lysis, protectin, p18, p-18, 1F5, MAC inhibitor, MEM-43, MACIP, MIC11</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD63, gp55, LIMP, MLA1, ME491, PTLGP40, LAMP-3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD65, CDw65, ceramide dodecasaccharide</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD65s, sialylated CD65, VIM-2, VIM2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD68, gp110, macrosialin (mouse)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD73, ecto 5&apos; nucleotidase (also in <class-ref scheme="cpc">C07K16/40</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD75, CDw75, lactosamine</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD75s, alpha-2-6-sialylated lactosamine</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD76, CDw76</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD77, BLA, Burkitt&apos;s lymphoma antigen, CTH, Gb3, globotriaosylceramide, Pk blood group antigen</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD78, CDw78, Ba</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD81, TAPA-1, target for anti-proliferative antigen 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD82, C33, IA4, KAI1, R2, 4F9</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD84, CDw84</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD87, uPAR, uPA-R, uPA receptor, urinary plasminogen activator receptor, urokinase-type plasminogen activator receptor, urokinase plasminogen activator receptor, Mo3, PLAUR, URKR, monocyte activation antigen, </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD88, C5aR, C5a-R, C5a receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD91, alpha2M-R, alpha2 macroglobulin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD92, CDw92, p70, CHTL1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD93, C1QR1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD97, BL-KDD/F12</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD98, FRP-1, RL-388 (mouse), 4F2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD99, E2, MIC2 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD99R</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD105, endoglin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD107</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD107a, LAMP-1, lysosome-associated membrane protein 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD107b, LAMP-2, lysosome-associated membrane protein 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD108, CDw108, JMH</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD109, 7D1, 8A3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD133, AC133, prominin-1, prominin-like 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD136, CDw136, macrophage-stimulating protein receptor, MSPR, MSP-R, MSP receptor, RON</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD138, syndecan-1, SDC-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD139, B-031</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD143, angiotensin-converting enzyme, carboxycathepsin, dipeptidyl carboxypeptidase, kininase II, peptidyl dipeptidase A, ACE (also in <class-ref scheme="cpc">C07K16/40</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD144, VE-cadherin, cadherin 5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD145, CDw145</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD148, DEP-1, HPTP-epsilon, p260, p260 phosphatase, HTPT-eta</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD149, CDw149, MEM-133</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD151, PETA-3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD155, PVR, polio virus receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD156, MADM, kuz, kuzbanian, HsT18717</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD156a, ADAM8, a disintegrin and metalloproteinase domain 8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD156b, CDw156C, ADAM17, a disintegrin and metalloproteinase domain 17, TACE</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD156c, CDw156C, ADAM10, a disintegrin and metalloproteinase domain 10</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD157, BST-1, BST1, BP-3/IF-7 (murine), Mo5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD162, PSGL1, PSGL-1, P-selectin ligand 1, TAIP, T cell apoptosis inducing protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD162R, PEN5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD163, GHI/61, M130</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD163L, CD163-L, CD163 ligand</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD164, MGC24, MGC-24</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD165, AD2, gp37</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD168, RHAMM</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD172a, SIRP alpha</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD174, Lewis Y, Ley, Le-Y</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD175, Tn</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD175s, sialyl-Tn</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD176, TF, Thomson Friedenreich</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD177, NB1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD180, RP105, RP-105</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD201, EPCR, EPC-R</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD203c, nucleotide pyrophosphatase/phosphodiesterase 3, phosphodiesterase 1/nucleotide pyrophosphatase 3, NPP3, E-NPP3, B10, gp130RBt3-6, PDNP3, Pdnpno, ENpp1 (also in <class-ref scheme="cpc">C07K16/40</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD204, macrophage scavenger receptor, MSR, MS-R</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD208, DC-LAMP</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD224, GGT, gamma-glutamyl transferase (also in <class-ref scheme="cpc">C07K16/40</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD225, Leu13, Leu-13</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD228, melanotransferrin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD231, A15, CCG-B7, MXS1, MXS-1, membrane component X chromosome surface marker 1, TALLA, T cell acute lymphoblastic leukemia-associated antigen, TM4SF2, TM4FS-2, transmembrane 4 superfamily member 2, TALLA-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD232, VESPR, VESP-R, VESP receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD233, band 3, SLC4A1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD234, DARC, Fy-glycoprotein, Duffy</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD235a, glycophorin A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD235b, glycophorin B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD235ab, glycophorin A/B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD236, glycophorin C/D</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD236R, glycophorin C</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD238, Kell</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD239, B-CAM</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD240CE, Rh30CE</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD240D, Rh30D</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD240DCE, Rh30D/CE crossreactive mAbs</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD241, RhAg, Rh50</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD243, MDR-1, P-glycoprotein, p170</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD245, p220/240</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD246, ALK, Ki-1, anaplastic lymphoma kinase (also in <class-ref scheme="cpc">C07K16/40</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD249, ENPEP, glutamyl aminopeptidase, aminopeptidase A, APA, gp160 (also in <class-ref scheme="cpc">C07K16/40</class-ref>) </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD281, TLR1, TLR-1, toll-like receptor 1, TIL, rsc786, KIAA0012, DKFZp547I0610, DKFZp564I0682</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD282, TLR2, TLR-2, toll-like receptor 2, TIL4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD283, TLR3, TLR-3, toll-like receptor 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD284, TLR4, TLR-4, toll-like receptor 4, TOLL, hToll</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD285, TLR5, Toll-like receptor 5, TIL3, Toll/interleukin-1 receptor like protein/antigen</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD286, TLR6, TLR-6, toll-like receptor 6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD287, TLR7, TLR-7, Toll-like receptor 7</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD288, TLR8, TLR-8, toll-like receptor 8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD289, TLR9, TLR-9, toll-like receptor 9</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD290, TLR10, TLR-10, toll-like receptor 10</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD291, TLR11, TLR-11, Toll-like receptor 11</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD294, GPR44, G-protein-coupled receptor 44, CRTH2, chemoattractant receptor-homologous molecule expressed on TH2 cells</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD296, ART1, ADP-ribosyltransferase 1, RT6 (also in <class-ref scheme="cpc">C07K16/40</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD297, ART4, Dombrook blood group, DOK1, DO (also in <class-ref scheme="cpc">C07K16/40</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD298, ATP1B3, ATPase Na+/K+ transporting beta3, ATPB-3, FLJ29027, sodium/potassium-dependent ATPase beta3, sodium/potassium-transporting ATPase beta-3 chain (also in <class-ref scheme="cpc">C07K16/40</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD311, EMR1, EGF-like module containing mucin-like hormone receptor-like 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD312, EMR2, EGF-like module containing mucin-like hormone receptor-like 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD313, EMR3, EGF-like module containing mucin-like hormone receptor-like 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD317, BST2, bone marrow stromal cell antigen 2, BST-2, HM1.24 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD318, CDCP1, CUB domain-containing protein 1, FLJ22969, MGC31813, SIMA135, TRASK, B345 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD320, 8D6A, 8D6, TCblR, transcobalamin receptor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD324, E-cadherin (epithelial), CDH1, cadherin 1 type 1, uvomorulin, cell-CAM 120/80, calcium-dependent adhesion protein (epithelial)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD325, N-cadherin (neuronal), CDH2, cadherin 2 type 1, calcium-dependent adhesion protein (neuronal), NCAD</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD338, CDw338, ABCG2, ATP-binding cassette subfamily G (white) member 2, MRX, MXR, ABCP, BCRP, BMDP, MXR1, MXR-1, ABC15, breast cancer resistance protein, mitoxantrone resistance protein, BCRP1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD339, JAG1, jagged 1, AGS, AHD, AWS, HJ1, JAGL1, jagged</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD344, Frizzled 4, FZD4, FZD-4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD349, Frizzled 9, FZD9, FZD-9, Fz-9, hFz9, FzE6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD350, Frizzled 10, FZD10, FZD-10, Fz-10, hFz10, FzE7</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD351, FCA/MR</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD355, CRTAM</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD361, EV12B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD362, syndecan-2, SDC2, HFGR1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/2896</class-ref> - CD363, SIPR1, EDG-1, CHEDG1</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - CD326, EpCAM, Ep-CAM, Ly74,TACSTD1, tumor-associated calcium signal transducer 1, 17-1A, CO17-1A, EGP40, GA733-2, KSA, ESA, EGP, M4S1, MIC18, TROP1, EGP-2, epithelial glycoprotein 2, EGP2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - Clusterin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - GPNMB, nmb, hematopoietic growth factor inducible neurokinin-1 protein, HGFIN, bone-related gene osteoactivin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - GPR49</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - KIAA0659</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - Labyrinthin, Lab</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - MH15</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - MN, CA IX, carbonic anhydrase IX, G-250, CA9 (also in <class-ref scheme="cpc">C07K16/40</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - 4Ig-B7-H3 (also in <class-ref scheme="cpc">C07K16/2827</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - MAGE-A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - MAGE-B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - MAGE-C</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - MAGE-D, NRAGE</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - MAGE-E</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - MAGE-F</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - MAGE-G</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - MAGE-H</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - MAGE-L</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - aMAGE</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - dMAGE</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - melanotransferrin, p9</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - Piwil2, piwi-like 2, PL2L</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - POTE</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - TROP2, TROP-2, EGP-1, EGP1, GA733, GA733-1, M1S1, epithelial glycoprotein 1, gastrointestinal tumor-associated antigen 1, tumor-associated calcium signal transducer 2, TACSTD2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/30</class-ref> - 5T4, 5T4AG, TPBG, M6P1, trophoblast glycoprotein </paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3007</class-ref> - CD66e, CEA, carcinoembryonic antigen, CEACAM5, CEACAM-5, carcinoembryonic antigen-related cell adhesion molecule 5</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3015</class-ref> - TIMP-2, tissue inhibitor of metalloproteinase 2</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3023</class-ref> - FAM3D</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/303</class-ref> - PaCa-Agl, 3C4-Ag</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/303</class-ref> - glypican 3, GPC3</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3053</class-ref> - MCSP, melanoma chondroitin sulfate proteoglycan, HMW-MAA, high molecular weight melanoma-associated antigen</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3053</class-ref> - Melan-A, MART-1</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3069</class-ref> - DD3, PCA3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3069</class-ref> - HPC2, human prostate cancer (predisposing gene) 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3069</class-ref> - protocadherin-PC, PTCH-PC</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3069</class-ref> - Piwil1, piwi-like 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3069</class-ref> - PSA, prostate-specific antigen, kallikrein 3, APS, KLK2A1, P-30 antigen, gamma seminoprotein, semenogelase, seminin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3069</class-ref> - PSCA, prostate stem cell antigen</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3069</class-ref> - PSMA, prostate-specific membrane antigen, glutamate carboxypeptidase II, N-acetylated alpha-linked acidic dipeptidase 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3069</class-ref> - PS118, PS-118</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3084</class-ref> - gangliosides</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3084</class-ref> - CD60, CDw60</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3084</class-ref> - CD60a, GD3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3084</class-ref> - CD60b, 9-O-acetal GD3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3084</class-ref> - CD60c, 7-O-acetyl-GD3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3084</class-ref> - GD1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3084</class-ref> - GD2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3084</class-ref> - GM1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3084</class-ref> - GM2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3084</class-ref> - GM3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3084</class-ref> - SC104</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3092</class-ref> - CD146, A32, MUC18, MUC-18, mucin 18, Mel-CAM, S-endo, MCAM, melanoma cell adhesion molecule</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3092</class-ref> - CD227, DF3, EMA, episialin, H23, mucin 1, MUC1, MUC-1, PEM, PUM, epithelial membrane antigen, peanut-reactive urinary mucin, polymorphic epithelial mucin, MAM-6, PAS-O, NPG, CA27.29</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3092</class-ref> - CSAp, colon-specific antigen p mucin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3092</class-ref> - MUC4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3092</class-ref> - MUC12</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3092</class-ref> - MUC16, CA-125</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3092</class-ref> - PAM4, PAM-4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3092</class-ref> - porimin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/3092</class-ref> - TAG-72, tumor-associated glycoprotein 72, CC49, B72.3</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/32</class-ref> - CD340, Her2, Her-2, ErbB2, ErbB-2, Neu, p185Her2, p185Neu, p185erbB2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/32</class-ref> - Her3, Her-3, ErbB3, ErbB-3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/32</class-ref> - Her4, Her-4, ErbB4, ErbB-4, tyro2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/32</class-ref> - MG20, CCNDBP1, cyclin D-type binding protein 1,</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/32</class-ref> - p95, N-truncated Her2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/32</class-ref> - MG20, CCNDBP1, cyclin D-type binding protein 1,</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/32</class-ref> - p95, N-truncated Her2 </paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/34</class-ref> - Blood group antigen</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/34</class-ref> - CD173, blood group H type 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/34</class-ref> - ABO antigens</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/34</class-ref> - HPA antigens </paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/36</class-ref> - CD141, thrombomodulin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/36</class-ref> - CD142, blood coagulation factor III, thrombokinin, TF, tissue factor protein, tissue thromboplastin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/36</class-ref> - Factor I, blood coagulation factor I, fibrinogen</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/36</class-ref> - Factor II, blood coagulation factor II, prothrombin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/36</class-ref> - Factor III, blood coagulation factor III, tissue thromboplastin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/36</class-ref> - Factor IV, blood coagulation factor IV</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/36</class-ref> - Factor V, blood coagulation factor V, proaccelerin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/36</class-ref> - Factor VII, blood coagulation factor VII, proconvertin </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/36</class-ref> - Factor VIII, blood coagulation factor VIII, antihemophilic factor, AHF, antihemophilic factor A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/36</class-ref> - Factor IX, blood coagulation factor IX, antihemophilic factor B, Christmas factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/36</class-ref> - Factor X, blood coagulation factor X, Stuart factor, Stuart-Prower factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/36</class-ref> - Factor XI, blood coagulation factor XI, plasma thromboplastin antecedent, antihemophilic factor C </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/36</class-ref> - Factor XII, blood coagulation factor XII, Hageman factor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/36</class-ref> - Factor XIII, blood coagulation factor XIII, fibrin-stabilizing factor, FSF</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/36</class-ref> - HMWK, high molecular weight kininogen, HMWK-kallikrein factor, Fitzgerald factor, Williams-Fitzgerald-Flaujeac factor, </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/36</class-ref> - vWF, von Willebrand&apos;s factor</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Protease inhibitors</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Alpha-1 antitrypsin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Antithrombin III</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Cystatins</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Cystatin 1, CST1, CST-1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Cystatin 2, CST2, CST-2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Cystatin 3, CST3, CST-3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Cystatin 4, CST4, CST-4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Cystatin 5, CST5, CST-5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Cystatin 6, CST6, CST-6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Cystatin 7, CST7, CST-7</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Cystatin 8, CST8, CST-8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Cystatin 8, CST8, CST-8</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Cystatin 9, CST9, CST-9</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Cystatin 11, CST11, CST-11</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Cystatin A, CSTA, CST-A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Cystatin B, CSTB, CST-B</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Cystatin C, CSTC, CST-C</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - HE4, whey acidic protein (WAP) four-disulfide core domain 2, major epididymis-specific protein E4, epididymal secretory protein E4, putative proteinase inhibitor WAP5.</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Megsin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Ovomucoid</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Pancreatic secretory inhibitor</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - Plasminogen activator inhibitors</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/38</class-ref> - TFPI, tissue factor pathway inhibitor, LACI, lipoprotein-associated coagulation factor, EPI, extrinsic pathway inhibitor</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - enzymes</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - CD10, CALLA, common acute lymphoblastic leukemia antigen, enkephalinase, gp100, NEP, neutral endopeptidase (also in <class-ref scheme="cpc">C07K16/2896</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - CD13, APN, aminopeptidase N, gp150 (also in <class-ref scheme="cpc">C07K16/2896</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - CD26, ADA binding protein, DPPIV, DPP IV, dipeptidyl peptidase IV (also in <class-ref scheme="cpc">C07K16/2896</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - CD143, angiotensin-converting enzyme, carboxycathepsin, dipeptidyl carboxypeptidase, kininase II, peptidyl dipeptidase A (also in <class-ref scheme="cpc">C07K16/2896</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - CD203c, nucleotide pyrophosphatase/phosphodiesterase 3, phosphodiesterase 1/nucleotide pyrophosphatase 3, NPP3, E-NPP3, B10, gp130RBt3-6, PDNP3, Pdnpno (also in <class-ref scheme="cpc">C07K16/2896</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - CD224, gamma-glutamyl transferase (also in <class-ref scheme="cpc">C07K16/2896</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - CD246, anaplastic lymphoma kinase (also in <class-ref scheme="cpc">C07K16/2896</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - CD249, ENPEP, glutamyl aminopeptidase, aminopeptidase A, APA, gp160 (also in <class-ref scheme="cpc">C07K16/2896</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - CD296, ART1, ADP-ribosyltransferase 1, RT6 (also in <class-ref scheme="cpc">C07K16/2896</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - CD297, ART4, Dombrook blood group, DOK1, DO (also in <class-ref scheme="cpc">C07K16/2896</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - CD298, ATP1B3, ATPase Na+/K+ transporting beta3, ATPB-3, FLJ29027, sodium/potassium-dependent ATPase beta3, sodium/potassium-transporting ATPase beta-3 chain (also in <class-ref scheme="cpc">C07K16/2896</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - ADAM10 (also in <class-ref scheme="cpc">C07K16/2896</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - ADAM12, meltrin alpha</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - ADAM19, meltrin beta</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - AKR1C1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - Cath, cathepsin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - Cath-D, cathepsin D</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - Ceruloplasnin</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - COX2, COX-2, cyclooxygenase 2, prostaglandin H2 synthase</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - FAP-alpha, fibroblast activating protein alpha, fibroblast activation factor, seprase</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - GPBP, Goodpasture antigen-binding protein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - HGFA, hepatocyte growth factor activator</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - HtrA, high temperature requirement A</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - HtrA1, high temperature requirement A1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - HtrA2, high temperature requirement A2, Omi</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - HtrA3, high temperature requirement A3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - HtrA3-L, high temperature requirement A3 long (isoform)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - HtrA3-S, high temperature requirement A3 short (isoform)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - HtrA4, high temperature requirement A4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - iNOS, inducible nitric oxide synthase, inducible NO synthase</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - Kallikrein</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - LOX, lysyl oxidase</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - LOXL1, LOR-1, lysyloxidase-related protein 1, lysyloxidase-like protein 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - LOXL2, LOR-2, lysyloxidase-related protein 2, lysyloxidase-like protein 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - LOXL3, LOR-3, lysyloxidase-related protein 3, lysyloxidase-like protein 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - LOXL4, LOR-4, lysyloxidase-related protein 4, lysyloxidase-like protein 4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - MASP1, MASP-1, MBL-associated serine protease 1</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - MASP2, MASP-2, MBL-associated serine protease 2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - MASP3, MASP-3, MBL-associated serine protease 3</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - Memapsin 2, BACE, BACE1, ASP-2, beta-secretase</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - MN, CA IX, carbonic anhydrase IX, G-250, CA9 (also in <class-ref scheme="cpc">C07K16/30</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - PCSK9, proprotein convertase subtilisin/kexin type 9, FH3, HCHOLA3, LDLCQ1, NARC-1, NARC1, PC9, PCS9</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - Protein C</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - Pyk-2</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - Seladin-1, selective Alzheimer&apos;s disease indicator 1, DHCR24, 24-dehydrocholesterol reductase</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - SLLP1, sperm-specific lysozyme-like protein 1, C19 </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - SLLP2, sperm-specific lysozyme-like protein 2, C23</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - SLLP3, sperm-specific lysozyme-like protein 3, C24</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - SLLP4, sperm-specific lysozyme-like protein 4</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - SLLP5, sperm-specific lysozyme-like protein 5</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - SLLP6, sperm-specific lysozyme-like protein 6</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref> - YKL-40, chondrex, HCGP39, HC-gp39, human cartilage glycoprotein 39, breast regression protein 39, Brp39</paragraph-text></list-item></list><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/44</class-ref> - Haptens</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/44</class-ref> - (Modified) amino acid residues</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/44</class-ref> - Metals</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K16/44</class-ref> - DNA, RNA</paragraph-text></list-item></list></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Valency</paragraph-text></table-column><table-column><paragraph-text type="body">Number of bonds formed between the antigen-binding molecule (e.g. an antibody or fragment thereof) and the target antigen</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">dAb, sdAb</paragraph-text></table-column><table-column><paragraph-text type="body">Single domain antibody</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">VHH, Nanobody&#174;</paragraph-text></table-column><table-column><paragraph-text type="body">Single domain antibody derived from camelids, e.g. camels, llamas, dromedaries, characterized by an extended CDR3 loop.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">VNAR</paragraph-text></table-column><table-column><paragraph-text type="body">Single domain antibody derived from cartilageous fishes, e.g. sharks, rays</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms><synonyms-keywords><section-title>Synonyms and Keywords</section-title><abbreviations>
      <paragraph-text type="preamble">In patent documents, the following abbreviations are often used:</paragraph-text>
      <table>
<table-row><table-column><paragraph-text type="body">Ig</paragraph-text></table-column><table-column><paragraph-text type="body">Immunoglobulin</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Ab</paragraph-text></table-column><table-column><paragraph-text type="body">Antibody</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">mAb, moAb</paragraph-text></table-column><table-column><paragraph-text type="body">Monoclonal antibody</paragraph-text></table-column></table-row></table>
      </abbreviations></synonyms-keywords></definition-item>
<definition-item><classification-symbol scheme="cpc">C07K17/00</classification-symbol><definition-title>Carrier-bound or immobilised peptides  (carrier-bound or immobilised enzymes <class-ref scheme="cpc">C12N11/00</class-ref>); Preparation thereof</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Peptides of any size, i.e. including proteins, that are immobilised or bound to a carrier, and processes for the immobilisation or for the binding of peptides to carriers.</paragraph-text></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">Immobilised or carrier-bound peptides being part of a functional device, are usually classified according to (the purpose of) the device, e.g. <class-ref scheme="cpc">A61M1/00</class-ref> for plasmapheresis, <class-ref scheme="cpc">B01J20/00</class-ref> for affinity chromatography and general sorbent materials.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N11/00</class-ref></paragraph-text><paragraph-text type="body">Immobilized or carrier-bound enzymes or microbial cells</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C07K1/00</class-ref></paragraph-text><paragraph-text type="body">Libraries of peptides</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N15/00</class-ref></paragraph-text><paragraph-text type="body">Screening of peptide libraries presented on the surface of microorganisms</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">G01N33/00</class-ref></paragraph-text><paragraph-text type="body">Analytical reagents/devices comprising immobilised or carrier-bound peptides, as well as methods involving the same</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C07K1/00</class-ref></paragraph-text><paragraph-text type="body">Use of immobilized peptides as stationary phases in affinity chromatography for the preparation of (other) peptides</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">A61K47/00</class-ref></paragraph-text><paragraph-text type="body">Peptides conjugated to carrier moieties in the context of the delivery of therapeutic agents</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">A61K51/00</class-ref></paragraph-text><paragraph-text type="body">Peptides conjugated to carrier moieties in the context of the delivery of diagnostic agents</paragraph-text></section-body></relationship><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><list><list-item><paragraph-text type="body">Immobilised or carrier-bound peptides that are enzymes or are part of microbial cells,</paragraph-text></list-item><list-item><paragraph-text type="body">- Processes and methods wherein the immobilised or carrier-bound peptides are used;</paragraph-text></list-item><list-item><paragraph-text type="body">- Processes for the immobilisation or for the binding of peptides to carriers, wherein said processes are specific for a peptide or a certain group of peptides. In these cases, the classification follows the specific peptide(s).</paragraph-text></list-item></list></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Particular attention is given to the nature of the solid support or the carrier and/or to the interaction of the peptide with it.</paragraph-text><paragraph-text type="body">When the immobilised or carrier-bound peptides is part of a functional device, and no special interaction of the peptide with the solid support or the carrier makes a contributions over the state of the art, no class within <class-ref scheme="cpc">C07K17/00</class-ref> is assigned.</paragraph-text><paragraph-text type="body">The last place rule is applicable to each different embodiment disclosed, if more than one is present.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Peptides </paragraph-text></table-column><table-column><paragraph-text type="body">compounds containing at least two amino acid units, which are bound through at least one normal peptide link, including oligopeptides, polypeptides and proteins.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Amino acids</paragraph-text></table-column><table-column><paragraph-text type="body">compounds in which at least one amino group and at least one carboxyl group are bound to the same carbon skeleton and the nitrogen atom of the amino group may form part of a ring.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Normal peptide link</paragraph-text></table-column><table-column><paragraph-text type="body">one between an alpha-amino group of an amino acid and the alpha-carboxy group of another alpha-amino acid.</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item date-revised="2023-08-01"><classification-symbol scheme="cpc">C07K19/00</classification-symbol><definition-title>Hybrid peptides {, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Peptides covalently linked to one or more nucleic acids; or, non-covalently bound complexes of two (or more) different peptides. This symbol is exclusively applied when a protein (or peptide) is covalently bonded to a nucleic acid, or when a non-covalent protein-protein complex is the core of the invention.</paragraph-text></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">Preparations for medical, dental, or toilet purposes are classified in <class-ref scheme="cpc">A61K</class-ref>.</paragraph-text><paragraph-text type="body">Hybrid immunoglobulins are classified in <class-ref scheme="cpc">C07K16/46</class-ref>.</paragraph-text><paragraph-text type="body">Chemically modified proteins, e.g. PEGylated, acylated or acetylated are classified in <class-ref scheme="cpc">C07K14/00</class-ref>.</paragraph-text><paragraph-text type="body">Covalently bound hybrid or heterologous peptides having more than 20 amino acids are classified in <class-ref scheme="cpc">C07K14/00</class-ref> and <class-ref scheme="cpc">C07K2319/00</class-ref> and subgroups, wherein each of the peptides forming the hybrid or heterologous molecule is classified per se in <class-ref scheme="cpc">C07K14/00</class-ref> and subgroups.</paragraph-text><paragraph-text type="body">Fusion proteins of an immunoglobulin with a peptide not being an immunoglobulin are classified in <class-ref scheme="cpc">C07K16/00</class-ref> and <class-ref scheme="cpc">C07K14/00</class-ref>.</paragraph-text><paragraph-text type="body">General processes for the preparation of hybrid peptides are classified in <class-ref scheme="cpc">C07K1/00</class-ref>.</paragraph-text><paragraph-text type="body">Genetic engineering processes for obtaining hybrid peptides are classified in <class-ref scheme="cpc">C12N15/00</class-ref>.</paragraph-text><paragraph-text type="body">Preparation of hybrid peptides and proteins by fermentation or enzyme-using processes are classified in <class-ref scheme="cpc">C12P21/00</class-ref>.</paragraph-text></section-body></relationship><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">General processes for the preparation of hybrid peptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K1/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chemically modified proteins, e.g. PEGylated, acylated or acetylated</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Fusion proteins of an immunoglobulin with a peptide not being an immunoglobulin</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref>, <class-ref scheme="cpc">C07K16/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides in foodstuffs</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Genetic engineering processes for obtaining hybrid peptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preparation of hybrid peptides and proteins by fermentation or enzyme-using processes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12P21/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Compositions for measuring or testing processes involving enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Investigation or analysis of biological material</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/00</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Looping references between <class-ref scheme="cpc">C07K19/00</class-ref> and <class-ref scheme="cpc">C07K16/46</class-ref> have been identified. Until this inconsistency is resolved in IPC, the current classification practice in CPC is as follows: Classify hybrid immunoglobulins composed solely of immunoglobulins in <class-ref scheme="cpc">C07K16/46</class-ref>.</paragraph-text></section-body></special-rules></definition-item></definitions>